https://curecurrent.com/trials/observational-study-to-evaluate-the-effectiveness-and-safety-of-the-dexcom-g4-continuous-glucose-monitoring-system-in-pe-5612 https://curecurrent.com/trials/the-usability-acceptability-and-perceived-value-of-the-cornerstones4care-powered-by-glooko-app-5613 https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetic-a-single-day-of-dosing-with-gsk1614235-5614 https://curecurrent.com/trials/a-study-to-determine-the-safety-tolerability-and-effects-of-gsk2374697-in-healthy-volunteers-5615 https://curecurrent.com/trials/changes-in-bone-turnover-with-increased-incretin-hormone-exposure-5616 https://curecurrent.com/trials/closed-loop-control-in-young-children-5-8-years-old-using-dias-platform-5617 https://curecurrent.com/trials/effects-of-ranolazine-on-coronary-flow-reserve-in-symptomatic-diabetic-patients-and-cad-5618 https://curecurrent.com/trials/physical-health-in-midlife-influences-of-adversity-and-relationships-over-time-5619 https://curecurrent.com/trials/walnut-consumption-and-diabetes-risk-5620 https://curecurrent.com/trials/outpatient-automated-blood-glucose-control-with-a-bi-hormonal-bionic-endocrine-pancreas-5621 https://curecurrent.com/trials/a-study-of-the-pharmacokinetics-of-albiglutide-in-normal-and-renally-impaired-subjects-5622 https://curecurrent.com/trials/treating-periodontal-infection-effects-on-glycemic-5623 https://curecurrent.com/trials/dose-ranging-study-to-evaluate-efficacy-and-safety-of-weekly-cjc-1134-pc-in-patients-with-t2dm-on-metformin-monotherapy-5624 https://curecurrent.com/trials/continuous-glucose-monitoring-in-women-with-type-1-diabetes-in-pregnancy-trial-5625 https://curecurrent.com/trials/pet-scan-imaging-of-beta-cell-mass-5626 https://curecurrent.com/trials/translating-the-dpp-into-the-community-5627 https://curecurrent.com/trials/grafixprime-for-the-treatment-of-chronic-diabetic-foot-ulcers-5628 https://curecurrent.com/trials/a-study-to-test-how-sb756050-affects-subjects-with-type-2-diabetes-mellitus-after-6-days-of-dosing-5629 https://curecurrent.com/trials/social-forces-to-improve-statin-adherence-study-b-5630 https://curecurrent.com/trials/interactive-spaced-education-to-optimize-diabetes-care-5631 https://curecurrent.com/trials/rapamycin-versus-mycophenolate-mofetil-in-kidney-pancreas-recipients-5632 https://curecurrent.com/trials/the-effect-of-pancreatic-polypeptide-on-insulin-requirements-for-type-1-post-pancreatectomy-diabetic-patients-5633 https://curecurrent.com/trials/freestyle-libre-flash-glucose-monitoring-system-accuracy-study-5634 https://curecurrent.com/trials/a-study-to-evaluate-the-effectiveness-safety-and-tolerability-of-canagliflozin-in-combination-with-metformin-in-the-trea-5635 https://curecurrent.com/trials/a-phase-1-study-to-evaluate-the-safety-and-tolerability-of-gsk1362885-in-healthy-normal-subjects-5636 https://curecurrent.com/trials/lifestyle-intervention-for-adults-with-diabetes-5637 https://curecurrent.com/trials/inducing-remission-in-type-1-diabetes-with-alefacept-5638 https://curecurrent.com/trials/a-prospective-randomized-double-blind-placebo-controlled-study-to-assess-the-impact-of-ormd-0801-insulin-capsules-on-the-5639 https://curecurrent.com/trials/assessment-of-insulin-production-from-native-pancreas-in-patients-with-pancreas-transplants-5640 https://curecurrent.com/trials/salivary-proteins-in-disease-and-health-5641 https://curecurrent.com/trials/methods-for-measuring-insulin-sensitivity-5642 https://curecurrent.com/trials/glycemic-response-to-six-meal-replacements-in-persons-with-type-2-diabetes-mellitus-5643 https://curecurrent.com/trials/insulin-secretory-defects-in-pima-indians-at-high-risk-for-niddm-5644 https://curecurrent.com/trials/metabolic-mapping-to-measure-retinal-metabolism-5645 https://curecurrent.com/trials/anti-tac-therapy-for-uveitis-5646 https://curecurrent.com/trials/assessment-of-beta-cell-mass-in-type-1-diabetes-with-11c-dihydrotetrabenazine-and-pet-scan-5647 https://curecurrent.com/trials/interventions-to-educate-an-underserved-population-about-inherited-disease-risks-5648 https://curecurrent.com/trials/pilot-study-of-mitochondrial-biology-in-human-platelets-5649 https://curecurrent.com/trials/evaluation-of-patients-with-known-or-suspected-heart-disease-5650 https://curecurrent.com/trials/evaluation-and-treatment-of-patients-with-retinal-disease-5651 https://curecurrent.com/trials/screening-for-studies-on-retinovascular-diseases-5652 https://curecurrent.com/trials/management-of-type-1-diabetes-among-adolescents-5653 https://curecurrent.com/trials/differences-in-genes-and-proteins-in-active-and-controlled-uveitis-5654 https://curecurrent.com/trials/eye-injections-of-triamcinolone-acetonide-for-retinal-blood-vessel-disorders-5655 https://curecurrent.com/trials/pilot-study-of-laser-photocoagulation-therapy-for-diabetic-macular-edema-5656 https://curecurrent.com/trials/identifying-the-role-of-oxytocin-and-vasopressin-in-the-functioning-of-neurocognitive-systems-involved-in-mood-disorders-5657 https://curecurrent.com/trials/mapping-of-end-stage-renal-disease-genetic-susceptibility-in-african-americans-by-admixture-linkage-disequilibrium-5658 https://curecurrent.com/trials/delaying-the-progression-of-diabetic-nephropathy-in-pima-indians-5659 https://curecurrent.com/trials/rosiglitazone-to-reverse-metabolic-defects-in-diabetes-5660 https://curecurrent.com/trials/accuracy-of-hemoglobin-a1c-to-predict-glycemia-in-hiv-5661 https://curecurrent.com/trials/treatment-of-diabetic-macular-edema-triamcinolone-injections-vs-laser-photocoagulation-5662 https://curecurrent.com/trials/autologous-stem-cell-and-hyperbaric-oxygen-therapy-in-type-2-diabetes-mellitus-5663 https://curecurrent.com/trials/relation-of-white-blood-cell-function-to-diabetes-5664 https://curecurrent.com/trials/the-roles-of-trust-and-respect-in-patient-reactions-to-race-based-and-personalized-medicine-vignettes-an-experimental-st-5665 https://curecurrent.com/trials/intravitreal-v-sub-tenon-injections-of-triamcinolone-acetonide-for-macular-edema-in-retinal-disorders-5666 https://curecurrent.com/trials/diabetes-management-personal-trainer-5667 https://curecurrent.com/trials/pilot-study-to-assess-the-proteome-in-human-atrial-tissue-5668 https://curecurrent.com/trials/rosiglitazone-to-treat-patients-with-heart-failure-and-glucose-intolerance-or-type-ii-diabetes-5669 https://curecurrent.com/trials/blood-factors-and-diabetic-retinopathy-5670 https://curecurrent.com/trials/food-intake-and-appetite-in-the-children-of-mothers-with-diabetes-5671 https://curecurrent.com/trials/effect-of-testosterone-in-men-with-erectile-dysfunction-5672 https://curecurrent.com/trials/glycemic-effects-of-morning-only-evening-only-or-twice-daily-insulin-glargine-in-patients-with-type-1-diabetes-5673 https://curecurrent.com/trials/comparison-of-outreach-approaches-to-increase-enrollment-in-a-healthy-cholesterol-study-5674 https://curecurrent.com/trials/neox-cord-1k-vs-standard-of-care-in-non-healing-diabetic-foot-ulcers-5675 https://curecurrent.com/trials/colesevelam-as-add-on-to-pioglitazone-therapy-for-type-2-diabetes-mellitus-5676 https://curecurrent.com/trials/cinnamon-bark-water-soluble-cinnamon-extract-and-metformin-for-treatment-of-type-2-dm-5677 https://curecurrent.com/trials/safety-and-efficacy-of-saxagliptin-for-glycemic-control-in-non-critically-ill-hospitalized-patient-5678 https://curecurrent.com/trials/a-drug-interaction-study-with-albiglutide-and-warfarin-5679 https://curecurrent.com/trials/reducing-problematic-substance-use-in-youth-with-chronic-medical-conditions-5680 https://curecurrent.com/trials/effects-of-exenatide-on-liver-biochemistry-liver-histology-and-lipid-metabolism-in-patients-with-fatty-liver-disease-5681 https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-gsk1362885-in-type-2-diabetics-5682 https://curecurrent.com/trials/first-time-in-human-study-using-gsk2330672-5683 https://curecurrent.com/trials/examining-the-effects-of-diet-on-health-in-prediabetes-with-an-online-program-5684 https://curecurrent.com/trials/utlight-transcranial-doppler-assessment-of-regional-cerebral-autoregulation-5685 https://curecurrent.com/trials/intervention-using-vitamin-d-for-elevated-urinary-albumin-treated-with-losartan-in-diabetes-ideal-5686 https://curecurrent.com/trials/using-health-information-technology-hit-to-improve-ambulatory-chronic-disease-care-smart-device-substudy-5687 https://curecurrent.com/trials/mechanisms-underlying-metabolic-syndrome-in-obesity-5688 https://curecurrent.com/trials/effect-of-dapagliflozin-on-24-hour-blood-glucose-in-t2dm-patients-inadequately-controlled-with-either-metformin-or-insul-5689 https://curecurrent.com/trials/clinical-protocol-to-investigate-the-efficacy-of-recombinant-human-leptin-metreleptin-in-nonalcoholic-steatohepatitis-na-5690 https://curecurrent.com/trials/a-study-to-investigate-the-interaction-of-gsk1292263-with-rosuvastatin-and-simvastatin-in-healthy-subjects-5691 https://curecurrent.com/trials/changes-in-bone-turnover-with-exposure-to-a-glp-1-receptor-agonist-5692 https://curecurrent.com/trials/role-of-mineralocorticoid-receptor-in-diabetic-cardiovascular-disease-5693 https://curecurrent.com/trials/an-evaluation-of-the-pharmacokinetics-of-an-oral-contraceptive-brevicon-when-co-administered-with-albiglutide-5694 https://curecurrent.com/trials/pancreatic-islet-cell-transplantation-5695 https://curecurrent.com/trials/a-phase-1-study-to-evaluate-the-effect-of-gsk256073-an-hm74a-receptor-agonist-on-glucose-and-nefa-levels-in-type-2-diabe-5696 https://curecurrent.com/trials/mhealth-skill-enhancement-plus-phone-cbt-for-type-2-diabetes-distress-medication-nonadherence-pilot-study-5697 https://curecurrent.com/trials/reteval-study-for-diabetic-retinopathy-5698 https://curecurrent.com/trials/use-of-the-paradigm-722-system-to-improve-glycemic-control-in-adult-and-adolescent-subjects-with-type-1-diabetes-5699 https://curecurrent.com/trials/a-drug-interaction-study-of-albiglutide-and-digoxin-5700 https://curecurrent.com/trials/protocol-for-the-evaluation-of-dario-bgms-performance-at-elevated-altitude-5701 https://curecurrent.com/trials/type-one-diabetes-and-low-carb-study-5702 https://curecurrent.com/trials/a-drug-interaction-study-of-simvastatin-and-albiglutide-5703 https://curecurrent.com/trials/a-2-part-trial-in-subjects-with-type-2-diabetes-and-in-healthy-subjects-to-evaluate-gsk1614235-a-new-glucose-lowering-dr-5704 https://curecurrent.com/trials/a-feasibility-study-of-advance-plasma-therapy001-plasma-nitric-oxide-therapy-for-the-treatment-of-diabetic-foot-ulcers-5705 https://curecurrent.com/trials/patient-and-provider-attitudes-in-the-healthcare-context-5706 https://curecurrent.com/trials/pilot-and-feasibility-study-for-the-treatment-of-pre-diabetes-in-patients-with-cystic-fibrosis-5707 https://curecurrent.com/trials/neurobiological-bases-of-paternal-nurturance-5708 https://curecurrent.com/trials/study-of-intensive-home-based-family-therapy-to-improve-illness-management-in-youth-with-diabetes-5709 https://curecurrent.com/trials/testing-mst-to-improve-adherence-among-youth-with-chronic-poor-metabolic-control-5710 https://curecurrent.com/trials/program-reinforcement-impacts-self-management-prism-5711 https://curecurrent.com/trials/computerized-intervention-of-parental-involvement-in-diabetes-care-of-their-child-5712 https://curecurrent.com/trials/home-based-interventions-for-adolescents-with-type-1-diabetes-5713 https://curecurrent.com/trials/reducing-stress-in-adolescents-and-young-adults-with-type-1-diabetes-to-improve-diabetes-care-5714 https://curecurrent.com/trials/effects-of-dpp-4-inhibition-on-calcium-and-bone-metabolism-in-type-2-diabetes-mellitus-5715 https://curecurrent.com/trials/the-effect-of-vasopressin-on-glucose-regulation-5716 https://curecurrent.com/trials/liraglutide-in-obesity-and-diabetes-identification-of-cns-targets-using-fmri-5717 https://curecurrent.com/trials/sitagliptin-therapy-to-improve-outcomes-after-islet-autotransplant-5718 https://curecurrent.com/trials/compare-effects-of-a-soluble-fiber-on-weight-and-blood-cholesterol-5719 https://curecurrent.com/trials/pk-study-of-dapagliflozin-in-pediatric-subjects-with-t2dm-5720 https://curecurrent.com/trials/can-whey-protein-improve-glycemic-control-in-type-2-diabetes-5721 https://curecurrent.com/trials/glycemic-control-using-insulin-levemir-versus-insulin-nph-for-diabetes-in-pregnancy-5722 https://curecurrent.com/trials/glycemic-stability-of-insulin-aspart-versus-insulin-lispro-in-insulin-pump-therapy-5723 https://curecurrent.com/trials/sitagliptin-therapy-in-hospitalized-patients-with-type-2-diabetes-5724 https://curecurrent.com/trials/one-day-acceptance-and-commitment-training-intervention-in-primary-care-patients-5725 https://curecurrent.com/trials/steroid-free-and-long-term-calcineurin-free-trial-in-islet-cell-transplantation-5726 https://curecurrent.com/trials/continuous-glucose-monitoring-evaluation-of-exenatide-twice-daily-versus-insulin-glargine-5727 https://curecurrent.com/trials/a-clinical-trial-comparing-efficacy-and-safety-of-insulin-degludec-liraglutide-ideglira-in-subjects-with-type-2-diabetes-5728 https://curecurrent.com/trials/pedometers-for-gestational-diabetes-5729 https://curecurrent.com/trials/three-way-cross-over-closed-loop-exercise-study-5730 https://curecurrent.com/trials/autoimmunity-blocking-antibody-for-tolerance-in-recently-diagnosed-type-1-diabetes-5731 https://curecurrent.com/trials/insulin-glargine-at-bedtime-or-in-am-versus-nph-5732 https://curecurrent.com/trials/prospective-study-of-the-impact-of-insulin-pump-therapy-in-young-children-with-type-1-diabetes-5733 https://curecurrent.com/trials/behavioral-family-systems-therapy-bfst-for-teens-with-type-2-diabetes-5734 https://curecurrent.com/trials/efficacy-and-safety-of-three-doses-of-vildagliptin-in-drug-naive-patients-with-type-2-diabetes-5735 https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-compared-to-rosiglitazone-in-drug-naive-patients-with-type-2-diabetes-5736 https://curecurrent.com/trials/pilot-study-of-using-copeptin-to-predict-response-to-tolvaptan-5737 https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-in-combination-with-pioglitazone-in-drug-naive-patients-with-type-2-diabetes-5738 https://curecurrent.com/trials/postmarket-study-to-evaluate-biovance-in-diabetic-foot-ulcers-5739 https://curecurrent.com/trials/safety-and-efficacy-of-aliskiren-when-added-to-standardized-losartan-and-optimal-antihypertensive-therapy-in-patients-wi-5740 https://curecurrent.com/trials/study-of-calcium-metabolism-in-teenage-girls-with-type-1-diabetes-5741 https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-safety-and-efficacy-of-aliskiren-alone-and-in-combination-with-ramipril-in-hypertensive-5742 https://curecurrent.com/trials/effectiveness-of-subcutaneous-glargine-on-the-time-to-closure-of-the-anion-gap-in-patients-presenting-to-the-emergency-d-5743 https://curecurrent.com/trials/cgm-to-aid-transition-from-inpatient-to-outpatient-5744 https://curecurrent.com/trials/assessment-of-an-intervention-to-prevent-obesity-and-diabetes-in-latino-farm-workers-5745 https://curecurrent.com/trials/safety-and-efficacy-of-combination-saxagliptin-dapagliflozin-added-to-metformin-to-treat-subjects-with-type-2-diabetes-5746 https://curecurrent.com/trials/multiple-daily-injections-and-continuous-glucose-monitoring-in-diabetes-5747 https://curecurrent.com/trials/computer-automation-for-diagnosis-and-management-of-childhood-type-2-diabetes-5748 https://curecurrent.com/trials/diabetic-retinopathy-and-the-myvisiontrack-drama-study-5749 https://curecurrent.com/trials/evaluation-of-an-ascensia-lancing-system-5750 https://curecurrent.com/trials/effect-of-angiotensin-converting-enzyme-inhibitor-lisinopril-on-renal-blood-flow-and-its-correlation-with-proteinuria-re-5751 https://curecurrent.com/trials/corticosteroid-therapy-on-glucose-control-in-pregnant-women-with-diabetes-5752 https://curecurrent.com/trials/study-of-antithymocyte-globulin-for-treatment-of-new-onset-t1dm-5753 https://curecurrent.com/trials/a-pilot-study-of-bms-512148-in-subjects-with-type-2-diabetes-5754 https://curecurrent.com/trials/effect-of-empagliflozin-kinetics-on-renal-glucose-reabsorption-in-patients-with-type-ii-diabetes-and-healthy-controls-5755 https://curecurrent.com/trials/effect-of-the-direct-renin-inhibitor-aliskiren-on-endothelial-function-and-arterial-stiffness-in-diabetic-subjects-5756 https://curecurrent.com/trials/comprehensive-intervention-to-evaluate-outcomes-and-cost-in-hospitalized-surgical-patients-with-diabetes-mellitus-dm-5757 https://curecurrent.com/trials/lifestyle-improvement-through-food-and-exercise-life-study-5758 https://curecurrent.com/trials/evaluation-of-the-precision-of-the-microperimetry-function-of-the-spectral-oct-slo-5759 https://curecurrent.com/trials/reduction-of-nocturnal-hypoglycemia-and-hyperglycemia-in-the-home-using-predictive-algorithms-pump-suspension-and-insuli-5760 https://curecurrent.com/trials/efficacy-and-safety-of-the-insulin-glargine-lixisenatide-fixed-ratio-combination-versus-insulin-glargine-in-patients-wit-5761 https://curecurrent.com/trials/tablet-aided-behavioral-intervention-effect-on-self-management-skills-5762 https://curecurrent.com/trials/lovaza-and-microvascular-function-in-type-2-diabetes-5763 https://curecurrent.com/trials/improving-diabetes-outcomes-for-persons-with-severe-mental-illness-5764 https://curecurrent.com/trials/a-comparison-of-tcc-ez-using-human-amnion-allograft-vs-tcc-ez-and-standard-wound-care-in-treating-diabetic-foot-ulcers-5765 https://curecurrent.com/trials/efficacy-and-safety-of-insulin-glargine-lixisenatide-fixed-ratio-combination-compared-to-insulin-glargine-alone-and-lixi-5766 https://curecurrent.com/trials/diabetes-remote-care-management-system-5767 https://curecurrent.com/trials/retinal-vessel-measurements-as-clinically-useful-predictors-in-veterans-5768 https://curecurrent.com/trials/the-effects-of-vitamin-d-on-glycemic-control-and-proinflammatory-markers-in-adolescents-with-t1dm-5769 https://curecurrent.com/trials/optical-imaging-for-assessment-of-foot-perfusion-5770 https://curecurrent.com/trials/nyulmc-caresmarts-pilot-5771 https://curecurrent.com/trials/a-clinical-trial-to-evaluate-pf-05089771-on-its-own-and-as-an-add-on-therapy-to-pregabalin-lyrica-for-the-treatment-of-p-5772 https://curecurrent.com/trials/the-effect-of-a-coloring-prompt-on-health-engagement-5773 https://curecurrent.com/trials/role-of-gastrointestinal-microbes-on-digestion-of-resistant-starch-and-tryptophan-availability-to-humans-5774 https://curecurrent.com/trials/medicaid-incentives-for-the-prevention-of-chronic-diseases-diabetes-prevention-5775 https://curecurrent.com/trials/effectiveness-of-patient-centered-community-health-worker-support-to-help-patients-control-chronic-disease-5776 https://curecurrent.com/trials/fresh-start-experiment-5777 https://curecurrent.com/trials/impact-of-dietary-intervention-on-weight-change-in-subjects-with-type-2-diabetes-5778 https://curecurrent.com/trials/neat-technology-to-increase-breaks-in-sedentary-behavior-in-adults-with-diabetes-5779 https://curecurrent.com/trials/health-information-technology-hit-enhanced-family-history-documentation-and-management-in-primary-care-5780 https://curecurrent.com/trials/ranibizumab-for-edema-of-the-macula-in-diabetes-protocol-3-with-high-dose-the-read-3-study-5781 https://curecurrent.com/trials/gapp-1-survey-global-attitudes-of-patients-and-physicians-in-insulin-therapy-for-diabetes-mellitus-5782 https://curecurrent.com/trials/long-term-clinical-evaluation-of-sls-transtibial-sockets-5783 https://curecurrent.com/trials/evaluation-of-fats-on-postprandial-glucose-control-5784 https://curecurrent.com/trials/effect-of-dietary-fat-on-glycemic-control-in-type-1-diabetes-5785 https://curecurrent.com/trials/the-effect-of-pecans-on-biomarkers-of-risk-for-cardiovascular-disease-and-diabetes-5786 https://curecurrent.com/trials/glycemic-index-variability-among-individuals-5787 https://curecurrent.com/trials/improving-self-management-skills-of-older-adults-with-diabetes-5788 https://curecurrent.com/trials/effectiveness-of-metformin-compared-to-insulin-in-pregnant-women-with-mild-preexisting-or-early-gestational-diabetes-5789 https://curecurrent.com/trials/induced-and-controlled-dietary-ketosis-as-a-regulator-of-obesity-and-metabolic-syndrome-pathologies-5790 https://curecurrent.com/trials/the-effect-of-tight-glycemic-control-on-surgical-site-infection-rates-in-patients-undergoing-open-heart-surgery-5791 https://curecurrent.com/trials/role-of-growth-hormone-antagonism-in-modulating-insulin-sensitivity-in-subjects-with-pre-diabetes-5792 https://curecurrent.com/trials/the-effects-of-puberty-and-weight-on-sugar-metabolism-in-children-5793 https://curecurrent.com/trials/the-role-of-amylin-and-incretins-on-postprandial-metabolisms-in-adolescents-with-type-2-diabetes-mellitus-t2dm-5794 https://curecurrent.com/trials/pancreatic-islet-cell-transplantation-a-novel-approach-to-improve-islet-quality-and-engraftment-5795 https://curecurrent.com/trials/a-pilot-study-to-assess-the-glucose-lowering-effect-of-metformin-and-sitagliptin-in-adolescents-with-type-1-diabetes-5796 https://curecurrent.com/trials/the-effect-of-byetta-and-symlin-on-post-meal-meal-blood-sugar-levels-in-children-with-type-2-diabetes-5797 https://curecurrent.com/trials/effects-of-dapagliflozin-on-insulin-resistance-and-insulin-secretion-in-subjects-with-type-2-diabetes-5798 https://curecurrent.com/trials/safety-and-efficacy-of-dapagliflozin-as-monotherapy-in-subjects-with-type-2-diabetes-5799 https://curecurrent.com/trials/primary-intervention-with-mucosal-insulin-5800 https://curecurrent.com/trials/metabolomic-analysis-of-hepatic-insulin-resistance-5801 https://curecurrent.com/trials/transcutaneous-raman-spectroscope-trs-analyses-of-diabetic-foot-ulcers-5802 https://curecurrent.com/trials/mindfulness-a-novel-approach-for-the-management-of-diabetes-related-distress-5803 https://curecurrent.com/trials/examining-the-role-of-cgm-in-t2dm-5804 https://curecurrent.com/trials/thiazolidinedione-intervention-with-vitamin-d-evaluation-5805 https://curecurrent.com/trials/a-safety-and-pharmacokinetic-study-of-cvx-096-in-type-2-diabetics-5806 https://curecurrent.com/trials/a-multicenter-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-saxagliptin-bms-47-5807 https://curecurrent.com/trials/effect-of-increasing-testosterone-on-insulin-sensitivity-in-men-with-the-metabolic-syndrome-5808 https://curecurrent.com/trials/efficacy-and-safety-of-lixisenatide-versus-placebo-on-top-of-basal-insulin-and-or-oral-antidiabetic-treatment-in-older-t-5809 https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-tolerability-and-pharmacokinetics-of-saxagliptin-as-monotherapy-in-pediatric-patie-5810 https://curecurrent.com/trials/characteristics-of-glargine-in-type-2-diabetics-5811 https://curecurrent.com/trials/fast-track-csii-using-a-novel-device-in-young-children-with-newly-diagnosed-t1dm-5812 https://curecurrent.com/trials/early-phase-pre-clinical-and-initial-clinical-research-on-epicatechin-5813 https://curecurrent.com/trials/effect-of-nutritional-products-in-subjects-with-type-2-diabetes-5814 https://curecurrent.com/trials/gluten-immunity-and-islet-autoimmunity-in-type-1-diabetes-5815 https://curecurrent.com/trials/prevalence-of-vitamin-d-deficiency-in-type-1-diabetes-mellitus-and-effect-of-supplementation-on-insulin-requirements-5816 https://curecurrent.com/trials/randomized-study-of-real-time-continuous-glucose-monitors-rt-cgm-in-the-management-of-type-1-diabetes-5817 https://curecurrent.com/trials/bioavailability-and-biological-effects-of-vitamin-d2-contained-in-mushroom-5818 https://curecurrent.com/trials/evaluate-safety-of-technosphere-insulin-ti-in-diabetic-subjects-with-moderate-obstructive-pulmonary-disease-5819 https://curecurrent.com/trials/bd-flowsmart-subcutaneous-insulin-infusion-set-user-preference-and-claims-study-5820 https://curecurrent.com/trials/genetics-of-latent-autoimmune-diabetes-in-adults-5821 https://curecurrent.com/trials/feasibility-study-of-digital-photography-and-group-discussion-for-people-with-diabetes-5822 https://curecurrent.com/trials/smoking-cessation-intervention-for-diabetic-patients-5823 https://curecurrent.com/trials/islet-cell-transplantation-in-patients-with-type-i-diabetes-with-previous-kidney-transplantation-5824 https://curecurrent.com/trials/brief-alcohol-intervention-to-reduce-at-risk-drinking-among-type-2-diabetics-5825 https://curecurrent.com/trials/processing-responses-of-grains-pro-grains-study-5826 https://curecurrent.com/trials/the-validate-d-study-5827 https://curecurrent.com/trials/par-regulation-of-platelet-function-in-diabetic-patients-5828 https://curecurrent.com/trials/study-of-the-effect-on-clinical-outcomes-using-secure-text-messaging-5829 https://curecurrent.com/trials/imaging-of-type-1-diabetes-progression-5830 https://curecurrent.com/trials/incretin-regulation-of-insulin-secretion-in-monogenic-diabetes-5831 https://curecurrent.com/trials/effects-of-continuous-positive-airway-pressure-cpap-treatment-on-glucose-control-in-patients-with-type-2-diabetes-5832 https://curecurrent.com/trials/confronting-unequal-eye-care-in-pennsylvania-5833 https://curecurrent.com/trials/safety-study-of-topical-doxycycline-gel-for-adult-diabetic-lower-extremity-ulcers-5834 https://curecurrent.com/trials/a-trial-comparing-efficacy-and-safety-of-insulin-degludec-and-insulin-glargine-in-insulin-na-ve-subjects-with-type-2-dia-5835 https://curecurrent.com/trials/aldosterone-and-glucose-homeostasis-5836 https://curecurrent.com/trials/comparison-of-nn1250-plus-insulin-aspart-with-insulin-glargine-plus-insulin-aspart-in-type-1-diabetes-5837 https://curecurrent.com/trials/comparison-of-nn1250-with-insulin-glargine-plus-insulin-aspart-with-without-metformin-and-with-without-pioglitazone-in-t-5838 https://curecurrent.com/trials/glargine-dosing-in-hospitalized-patients-with-type-2-diabetes-and-renal-insufficiency-5839 https://curecurrent.com/trials/truskin-study-for-the-treatment-of-chronic-diabetic-foot-ulcers-5840 https://curecurrent.com/trials/changing-the-healthcare-delivery-model-5841 https://curecurrent.com/trials/a-3-month-clinical-trial-to-assess-the-safety-and-efficacy-of-the-ozurdex-intraocular-implant-in-patients-with-diabetes-5842 https://curecurrent.com/trials/university-of-texas-h-s-c-san-antonio-pioglitazone-in-non-alcoholic-steatohepatitis-trial-uthscsa-nash-trial-5843 https://curecurrent.com/trials/behavioral-economics-incentives-for-health-management-5844 https://curecurrent.com/trials/islet-cell-transplantation-alone-and-cd34-donor-bone-marrow-cell-infusion-in-type-1-diabetes-mellitus-5845 https://curecurrent.com/trials/effect-of-renal-impairment-on-the-pharmacokinetics-of-nn9535-5846 https://curecurrent.com/trials/the-ranibizumab-for-edema-of-the-macula-in-diabetes-2-read-2-study-5847 https://curecurrent.com/trials/propranolol-for-diabetic-retinopathy-5848 https://curecurrent.com/trials/gestational-diabetes-follow-up-study-5849 https://curecurrent.com/trials/strength-training-and-nutrition-development-for-african-american-youth-5850 https://curecurrent.com/trials/strength-and-nutrition-outcomes-for-latino-adolescents-5851 https://curecurrent.com/trials/islet-transplantation-in-type-1-diabetic-patients-5852 https://curecurrent.com/trials/glycemic-control-and-complications-in-diabetes-mellitus-type-2-vadt-5853 https://curecurrent.com/trials/efficacy-and-safety-of-liraglutide-in-subjects-with-type-1-diabetes-undergoing-islet-cell-transplantation-5854 https://curecurrent.com/trials/non-invasive-assessment-of-wound-healing-with-optical-methods-5855 https://curecurrent.com/trials/diet-as-a-potential-treatment-for-autosomal-dominant-polycystic-kidney-disease-5856 https://curecurrent.com/trials/assess-the-efficacy-of-the-low-glucose-suspend-lgs-feature-in-the-minimed-paradigm-x54-system-5857 https://curecurrent.com/trials/comparison-of-the-effectiveness-and-tolerability-of-exenatide-once-weekly-compared-to-basal-insulins-5858 https://curecurrent.com/trials/phase-2-study-to-evaluate-safety-efficacy-of-vpi-2690b-in-diabetic-nephropathy-patients-5859 https://curecurrent.com/trials/the-effect-of-aliskiren-on-endothelial-function-in-pre-diabetes-and-diabetes-5860 https://curecurrent.com/trials/efficacy-safety-and-preference-study-of-a-insulin-pen-pds290-vs-a-novo-nordisk-marketed-insulin-pen-in-diabetics-5861 https://curecurrent.com/trials/the-effects-of-alpha-1-antitrypsin-aat-on-the-progression-of-type-1-diabetes-5862 https://curecurrent.com/trials/rosiglitazone-versus-a-sulfonylurea-on-progression-of-atherosclerosis-in-patients-with-heart-disease-and-type-2-diabetes-5863 https://curecurrent.com/trials/study-in-people-with-type-2-diabetes-5864 https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-liraglutide-depot-in-healthy-subjects-5865 https://curecurrent.com/trials/a-randomised-trial-comparing-efficacy-and-safety-after-intensification-with-either-insulin-aspart-once-daily-as-add-on-o-5866 https://curecurrent.com/trials/the-fasting-ii-study-5867 https://curecurrent.com/trials/a-study-of-ly2405319-in-participants-with-type-2-diabetes-5868 https://curecurrent.com/trials/the-fenofibrate-and-metformin-for-atherogenic-dyslipidemia-fama-study-5869 https://curecurrent.com/trials/changes-in-inflammatory-state-in-asian-americans-changing-from-traditional-asian-diets-to-american-diet-a-pilot-study-5870 https://curecurrent.com/trials/comparison-of-nn5401-plus-insulin-aspart-with-insulin-detemir-plus-insulin-aspart-in-type-1-diabetes-5871 https://curecurrent.com/trials/comparison-of-nn5401-with-insulin-glargine-both-in-combination-with-oral-antidiabetic-drugs-in-subjects-with-type-2-diab-5872 https://curecurrent.com/trials/together-on-diabetes-study-evaluation-of-a-pilot-diabetes-prevention-and-management-program-for-american-indian-youth-5873 https://curecurrent.com/trials/efficacy-and-safety-of-insulin-degludec-insulin-aspart-in-insulin-na-ve-subjects-with-type-2-diabetes-using-two-dosing-r-5874 https://curecurrent.com/trials/assessment-of-an-automatic-closed-loop-insulin-delivery-system-5875 https://curecurrent.com/trials/screening-for-asymptomatic-obstructive-coronary-artery-disease-among-high-risk-diabetic-patients-using-ct-angiography-fo-5876 https://curecurrent.com/trials/safety-and-efficacy-study-of-correcting-hyperglycemia-in-patients-with-diabetes-having-out-patient-surgery-5877 https://curecurrent.com/trials/islet-transplantation-for-type-1-diabetes-5878 https://curecurrent.com/trials/use-of-santyl-within-an-accountable-care-organization-5879 https://curecurrent.com/trials/effect-of-detemir-and-sitagliptin-on-blood-glucose-control-in-type-2-diabetes-5880 https://curecurrent.com/trials/insulin-clamp-ancillary-study-for-assessment-of-insulin-resistance-5881 https://curecurrent.com/trials/promoting-adherence-to-improve-effectiveness-of-cardiovascular-disease-therapies-5882 https://curecurrent.com/trials/atorvastatin-in-new-onset-type-1-diabetes-mellitus-t1dm-5883 https://curecurrent.com/trials/effect-of-two-different-fasting-blood-glucose-targets-on-glucose-control-in-patients-with-type-2-diabetes-using-insulin-5884 https://curecurrent.com/trials/comparison-of-the-blood-sugar-lowering-effect-and-safety-of-two-insulin-treatments-in-type-2-diabetes-5885 https://curecurrent.com/trials/effect-of-insulin-detemir-and-insulin-glargine-on-blood-glucose-control-in-subjects-with-type-2-diabetes-5886 https://curecurrent.com/trials/a-trial-to-assess-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-single-doses-of-pf-04937319-in-subjec-5887 https://curecurrent.com/trials/pilot-study-of-bydureon-to-treat-diabetes-in-hiv-infected-adults-5888 https://curecurrent.com/trials/mga031-sirolimus-and-tacrolimus-in-islet-transplantation-5889 https://curecurrent.com/trials/one-step-versus-two-step-approach-for-gestational-diabetes-mellitus-screening-5890 https://curecurrent.com/trials/community-based-diabetes-care-for-korean-american-immigrants-5891 https://curecurrent.com/trials/effects-of-dapagliflozin-on-kidney-function-glomerular-filtration-rate-in-subjects-with-type-2-diabetes-5892 https://curecurrent.com/trials/effect-of-liraglutide-or-exenatide-added-to-an-ongoing-treatment-on-blood-glucose-control-in-subjects-with-type-2-diabet-5893 https://curecurrent.com/trials/the-effect-of-insulin-detemir-in-combination-with-liraglutide-and-metformin-compared-to-liraglutide-and-metformin-in-sub-5894 https://curecurrent.com/trials/the-effect-of-liraglutide-versus-placebo-when-added-to-basal-insulin-analogues-with-or-without-metformin-in-subjects-wit-5895 https://curecurrent.com/trials/the-effect-of-liraglutide-on-endothelial-function-in-subjects-with-type-2-diabetes-mellitus-5896 https://curecurrent.com/trials/the-effect-of-liraglutide-compared-to-sitagliptin-both-in-combination-with-metformin-on-glycaemic-control-in-subjects-wi-5897 https://curecurrent.com/trials/to-evaluate-the-effect-of-liraglutide-versus-glimepiride-amaryl-on-haemoglobin-a1c-5898 https://curecurrent.com/trials/a-trial-comparing-the-efficacy-patient-reported-outcomes-and-safety-of-insulin-degludec-200-u-ml-vs-insulin-glargine-in-5899 https://curecurrent.com/trials/comparing-the-efficacy-and-safety-of-nn1250-once-daily-when-titrated-using-2-different-algorithms-in-insulin-na-ve-subje-5900 https://curecurrent.com/trials/comparison-of-the-efficacy-and-safety-of-two-intensification-strategies-in-subjects-with-type-2-diabetes-inadequately-co-5901 https://curecurrent.com/trials/the-efficacy-and-safety-of-liraglutide-as-adjunct-therapy-to-insulin-in-the-treatment-of-type-1-diabetes-5902 https://curecurrent.com/trials/comparison-of-two-insulin-degludec-formulations-in-subjects-with-type-2-diabetes-mellitus-5903 https://curecurrent.com/trials/marlina-t2d-efficacy-safety-modification-of-albuminuria-in-type-2-diabetes-subjects-with-renal-disease-with-linagliptin-5904 https://curecurrent.com/trials/comparison-of-nn1250-with-insulin-glargine-in-subjects-with-type-2-diabetes-5905 https://curecurrent.com/trials/comparison-of-nn1250-with-insulin-glargine-in-subjects-with-type-2-diabetes-5906 https://curecurrent.com/trials/comparison-of-nn1250-with-insulin-glargine-in-subjects-with-type-2-diabetes-5907 https://curecurrent.com/trials/t1-diabetes-hypoglycemia-prevention-pilot-5908 https://curecurrent.com/trials/comparison-of-two-nn1250-formulations-versus-insulin-glargine-all-in-combination-with-insulin-aspart-in-subjects-with-ty-5909 https://curecurrent.com/trials/comparison-of-nn1250-with-sitagliptin-in-subjects-with-type-2-diabetes-never-treated-with-insulin-5910 https://curecurrent.com/trials/evaluation-of-blood-pressure-reduction-safety-and-tolerability-of-canagliflozin-in-patients-with-hypertension-and-type-2-5911 https://curecurrent.com/trials/a-phase-i-single-ascending-dose-study-of-the-intravitreal-plasma-kallikrein-inhibitor-kvd001-in-subjects-with-dme-5912 https://curecurrent.com/trials/a-pilot-study-of-nocturnal-hypoglycemia-prevention-in-type-1-diabetes-using-the-vigilant-diabetes-management-companion-5913 https://curecurrent.com/trials/comparison-of-two-nn1250-formulations-versus-insulin-glargine-all-in-combination-with-metformin-in-subjects-with-type-2-5914 https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-pharmacodynamics-and-safety-of-canagliflozin-in-older-children-and-adolescents-5915 https://curecurrent.com/trials/efficacy-of-exenatide-lar-and-dapagliflozin-in-overweight-obese-insulin-treated-patients-with-type-2-diabetes-5916 https://curecurrent.com/trials/impaired-wound-healing-in-diabetic-foot-ulceration-5917 https://curecurrent.com/trials/extension-to-a-study-on-the-efficacy-and-safety-of-vildagliptin-in-combination-with-metformin-in-patients-with-type-2-di-5918 https://curecurrent.com/trials/extension-to-a-study-to-assess-the-efficacy-and-safety-of-three-doses-of-vildagliptin-in-patients-with-type-2-diabetes-5919 https://curecurrent.com/trials/extension-to-a-study-on-the-efficacy-and-safety-of-vildagliptin-in-combination-with-glimepiride-in-patients-with-type-2-5920 https://curecurrent.com/trials/evaluation-of-exenatide-in-patients-with-diabetic-neuropathy-5921 https://curecurrent.com/trials/the-effect-of-add-on-canagliflozin-in-patients-with-type-2-diabetes-treated-with-u-500-insulin-5922 https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-albiglutide-in-subjects-with-type-2-diabetes-with-renal-impairment-5923 https://curecurrent.com/trials/cardiovascular-outcomes-study-of-naltrexone-sr-bupropion-sr-in-overweight-and-obese-subjects-with-cardiovascular-risk-fa-5924 https://curecurrent.com/trials/mindfulness-based-personalized-health-planning-for-reducing-risk-of-heart-disease-and-diabetes-5925 https://curecurrent.com/trials/autonomic-function-in-obstructive-sleep-apnea-5926 https://curecurrent.com/trials/safety-and-efficacy-of-nateglinide-in-patients-with-type-2-diabetes-already-taking-insulin-glargine-metformin-and-or-pio-5927 https://curecurrent.com/trials/efficacy-of-biphasic-insulin-aspart-30-in-type-2-diabetics-failing-on-oads-5928 https://curecurrent.com/trials/thrombospondin-1-and-pigmented-epithelium-derived-factor-levels-in-patients-with-diabetes-mellitus-5929 https://curecurrent.com/trials/a-study-to-determine-the-efficacy-and-safety-of-albiglutide-as-compared-with-liraglutide-5930 https://curecurrent.com/trials/the-cantata-m-canagliflozin-treatment-and-trial-analysis-monotherapy-trial-5931 https://curecurrent.com/trials/the-mobile-health-platform-5932 https://curecurrent.com/trials/a-study-of-aleglitazar-in-combination-with-metformin-in-patients-with-type-2-diabetes-mellitus-who-are-inadequately-cont-5933 https://curecurrent.com/trials/designer-functional-foods-on-parameters-of-metabolic-and-vascular-in-prediabetes-5934 https://curecurrent.com/trials/effect-of-vildagliptin-on-fat-and-muscle-metabolism-in-patients-with-type-2-diabetes-5935 https://curecurrent.com/trials/exploring-folk-health-practices-in-latinos-with-chronic-medical-conditions-5936 https://curecurrent.com/trials/regulating-efficacy-and-wellness-in-diabetes-5937 https://curecurrent.com/trials/extension-to-a-study-on-the-efficacy-and-safety-of-vildagliptin-in-combination-with-pioglitazone-in-patients-with-type-2-5938 https://curecurrent.com/trials/add-on-to-thiazolidinedione-tzd-failures-5939 https://curecurrent.com/trials/effect-of-repaglinide-on-postprandial-lipemia-in-type-2-diabetes-5940 https://curecurrent.com/trials/efficacy-and-safety-of-basal-bolus-therapy-comparing-stepwise-addition-of-insulin-aspart-versus-complete-basal-bolus-reg-5941 https://curecurrent.com/trials/a-6-week-study-of-pf-05175157-in-type-2-diabetes-mellitus-5942 https://curecurrent.com/trials/evaluation-of-blood-glucose-monitoring-systems-with-blood-samples-from-neonates-5943 https://curecurrent.com/trials/pancreatic-islet-cell-transplantation-after-kidney-transplantation-a-novel-approach-to-immunosupression-5944 https://curecurrent.com/trials/a-study-to-evaluate-safety-and-efficacy-of-ttp054-for-12-weeks-in-subjects-with-type-2-diabetes-5945 https://curecurrent.com/trials/efficacy-and-safety-of-insulin-glargine-lixisenatide-fixed-combination-versus-insulin-glargine-alone-on-top-of-metformin-5946 https://curecurrent.com/trials/add-glucokinase-activator-to-target-a1c-5947 https://curecurrent.com/trials/bms-safety-pharmacokinetics-pk-and-pharmacodynamics-pd-of-dapagliflozin-in-type-1-diabetes-5948 https://curecurrent.com/trials/a-study-to-evaluate-safety-and-efficacy-of-ttp273-for-12-weeks-in-subjects-with-type-2-diabetes-5949 https://curecurrent.com/trials/glycemic-efficacy-and-renal-safety-study-of-dapagliflozin-in-subjects-with-type-2-diabetes-mellitus-and-moderate-renal-i-5950 https://curecurrent.com/trials/a-randomized-control-trial-comparing-linjeta-versus-humalog-in-pumps-effect-on-postprandial-blood-sugars-5951 https://curecurrent.com/trials/evaluation-of-an-investigational-blood-glucose-monitoring-system-5952 https://curecurrent.com/trials/single-dose-pharmacokinetics-of-repaglinide-metformin-and-combination-tablet-in-fed-healthy-volunteers-5953 https://curecurrent.com/trials/a-study-for-pre-diabetic-patients-with-cholesterol-lowering-drugs-5954 https://curecurrent.com/trials/effect-of-repaglinide-and-metformin-combination-tablet-or-rosiglitazone-and-metformin-in-fixed-dose-combination-on-blood-5955 https://curecurrent.com/trials/single-dose-pharmacokinetics-of-repaglinide-metformin-and-combination-tablet-in-healthy-volunteers-5956 https://curecurrent.com/trials/assessing-inherited-markers-of-metabolic-syndrome-in-the-young-5957 https://curecurrent.com/trials/comparison-of-nn1250-versus-insulin-glargine-in-subjects-with-type-2-diabetes-5958 https://curecurrent.com/trials/monitoring-the-infusion-pressure-in-insulin-infusion-sets-in-healthy-adults-5959 https://curecurrent.com/trials/comparison-of-nn1250-with-insulin-glargine-in-type-1-diabetes-5960 https://curecurrent.com/trials/clinical-evaluation-of-bd-next-pen-needle-5961 https://curecurrent.com/trials/managing-wounds-with-allevyn-life-in-a-home-health-care-environment-5962 https://curecurrent.com/trials/the-efficacy-and-safety-of-liraglutide-adjunct-to-insulin-treatment-in-type-1-diabetes-5963 https://curecurrent.com/trials/anti-diabetic-effects-of-liraglutide-in-adolescents-and-young-subjects-with-type-1-diabetes-5964 https://curecurrent.com/trials/evaluation-of-a-diabetes-vaccine-in-newly-diagnosed-diabetics-5965 https://curecurrent.com/trials/ascertainment-of-emr-based-clinical-covariates-among-patients-receiving-oral-and-non-insulin-injected-hypoglycemic-thera-5966 https://curecurrent.com/trials/treatment-with-hokt3gamma1-ala-ala-in-t1dm-5967 https://curecurrent.com/trials/proleukin-and-rapamune-in-type-1-diabetes-5968 https://curecurrent.com/trials/the-management-of-glucocorticoid-induced-hyperglycemia-in-hospitalized-patients-5969 https://curecurrent.com/trials/single-dose-study-to-evaluate-safety-tolerability-and-pharmacodynamics-of-remd-477-in-subjects-with-type-1-diabetes-mell-5970 https://curecurrent.com/trials/vildagliptin-compared-to-pioglitazone-in-combination-with-metformin-in-patients-with-type-2-diabetes-5971 https://curecurrent.com/trials/comparison-of-two-treatments-for-multivessel-coronary-artery-disease-in-individuals-with-diabetes-freedom-5972 https://curecurrent.com/trials/effects-of-hyperglycemia-during-cardiopulmonary-bypass-on-renal-function-5973 https://curecurrent.com/trials/arterial-stiffness-in-type-i-diabetes-mellitus-5974 https://curecurrent.com/trials/text-messaging-to-promote-walking-among-latino-adults-at-risk-for-peripheral-arterial-disease-5975 https://curecurrent.com/trials/mechanisms-of-diabetes-relapse-after-bariatric-surgery-5976 https://curecurrent.com/trials/the-effect-of-ly333531-on-protein-in-the-urine-in-patients-with-type-2-diabetes-5977 https://curecurrent.com/trials/multiple-dose-study-of-pf-04937319-in-patients-with-type-2-diabetes-5978 https://curecurrent.com/trials/safety-and-efficacy-of-endobarrier-in-subjects-with-type-2-diabetes-who-are-obese-5979 https://curecurrent.com/trials/roflumilast-plus-alogliptin-proof-of-mechanism-study-in-type2-diabetes-5980 https://curecurrent.com/trials/phase-2-study-to-evaluate-safety-and-efficacy-of-investigational-drug-pf04937319-in-patients-with-type-2-diabetes-5981 https://curecurrent.com/trials/study-to-understand-efficacy-and-safety-of-investigational-agent-pf-04937319-compared-to-approved-agent-glimepiride-in-p-5982 https://curecurrent.com/trials/comparison-of-self-adjustment-versus-standard-of-care-treatment-in-subjects-with-type-2-diabetes-5983 https://curecurrent.com/trials/comparison-of-insulin-detemir-with-insulin-glargine-in-type-2-diabetes-5984 https://curecurrent.com/trials/mitochondrial-related-platelet-transcript-expression-levels-in-pre-diabetic-subjects-randomized-to-metformin-or-placebo-5985 https://curecurrent.com/trials/comparison-of-insulin-detemir-morning-insulin-detemir-evening-and-nph-insulin-evening-in-patients-with-type-2-diabetes-5986 https://curecurrent.com/trials/canagliflozin-treatment-and-trial-analysis-sulfonylurea-cantata-su-sglt2-add-on-to-metformin-versus-glimepiride-5987 https://curecurrent.com/trials/mobile-technology-online-tools-to-track-adherence-in-chronic-illness-patients-5988 https://curecurrent.com/trials/study-to-evaluate-the-effect-of-bydureon-on-24-hour-glucose-control-in-metformin-treated-patients-with-type-2-diabetes-5989 https://curecurrent.com/trials/safety-and-efficacy-of-insulin-detemir-plus-insulin-aspart-against-insulin-glargine-plus-insulin-aspart-as-mealtime-insu-5990 https://curecurrent.com/trials/a-study-to-evaluate-cardiovascular-outcomes-in-patients-with-type-2-diabetes-treated-with-itca-650-5991 https://curecurrent.com/trials/comparison-of-insulin-detemir-or-insulin-glargine-as-add-on-to-oral-antidiabetic-drugs-in-type-2-diabetes-5992 https://curecurrent.com/trials/comparison-of-insulin-detemir-plus-insulin-aspart-against-insulin-glargine-plus-insulin-aspart-in-type-2-diabetes-5993 https://curecurrent.com/trials/pharmacokinetics-of-insulin-detemir-in-subjects-with-type-2-diabetes-5994 https://curecurrent.com/trials/a-study-to-examine-changes-in-gip-plasma-levels-following-gastric-bypass-surgery-in-obese-patients-5995 https://curecurrent.com/trials/efficacy-and-safety-of-metformin-and-liraglutide-in-obese-subjects-with-type-2-diabetes-previously-treated-with-an-oral-5996 https://curecurrent.com/trials/effect-of-liraglutide-on-the-beta-cell-responsiveness-in-subjects-with-type-2-diabetes-compared-to-a-healthy-control-gro-5997 https://curecurrent.com/trials/examination-of-the-effects-of-liraglutide-on-the-mode-of-action-of-insulin-detemir-5998 https://curecurrent.com/trials/a-study-of-bms-512148-dapagliflozin-in-patients-with-type-2-diabetes-and-inadequately-controlled-hypertension-on-an-angi-5999 https://curecurrent.com/trials/pk-pd-study-of-gan-lee-s-insulin-glargine-injection-in-comparison-to-lantus-in-type-1-diabetes-6000 https://curecurrent.com/trials/safety-of-liraglutide-in-pediatric-patients-with-type-2-diabetes-6001 https://curecurrent.com/trials/effects-of-prevena-therapy-on-obese-and-or-diabetic-patients-with-surgical-groin-sites-6002 https://curecurrent.com/trials/effect-of-liraglutide-on-blood-glucose-control-in-subjects-with-type-2-diabetes-6003 https://curecurrent.com/trials/effect-of-liraglutide-on-heart-frequency-in-healthy-volunteers-6004 https://curecurrent.com/trials/glucose-variability-pilot-study-for-the-abbott-sensor-based-glucose-monitoring-system-professional-6005 https://curecurrent.com/trials/accuracy-characterization-study-6006 https://curecurrent.com/trials/personalized-health-planning-in-shared-medical-appointments-for-individuals-with-type-ii-diabetes-pilot-study-6007 https://curecurrent.com/trials/the-effect-of-nn1250-in-subjects-with-type-2-diabetes-of-different-race-and-or-ethnic-origin-6008 https://curecurrent.com/trials/weight-changes-during-and-after-pregnancy-in-women-with-gestational-diabetes-6009 https://curecurrent.com/trials/a-trial-comparing-sequential-addition-of-insulin-aspart-versus-further-dose-increase-with-insulin-degludec-liraglutide-i-6010 https://curecurrent.com/trials/diabetes-attitudes-wishes-and-needs-6011 https://curecurrent.com/trials/comparison-of-glycemic-control-achieved-with-2-different-needles-6012 https://curecurrent.com/trials/a-study-to-investigate-the-safety-and-metabolism-of-gsk376501-in-overweight-subjects-6013 https://curecurrent.com/trials/neck-grasp-as-a-predictor-of-sleep-apnea-6014 https://curecurrent.com/trials/a-trial-investigating-nn1218-in-subjects-with-type-1-and-type-2-diabetes-6015 https://curecurrent.com/trials/ziprasidone-for-clozapine-or-olanzapine-associated-diabetes-mellitus-6016 https://curecurrent.com/trials/alliance-to-control-diabetes-6017 https://curecurrent.com/trials/gapp-2-survey-global-attitudes-of-patients-and-physicians-in-insulin-therapy-for-type-2-diabetes-mellitus-6018 https://curecurrent.com/trials/vaccine-efficacy-in-diabetic-and-elderly-patients-6019 https://curecurrent.com/trials/switching-from-one-type-of-anti-rejection-drug-tacrolimus-or-cyclosporine-to-another-sirolimus-approximately-90-180-days-6020 https://curecurrent.com/trials/comparison-of-biphasic-insulin-aspart-70-30-versus-insulin-glargine-in-subjects-with-type-2-diabetes-6021 https://curecurrent.com/trials/albiglutide-glucose-clamp-study-in-subjects-with-type-2-diabetes-6022 https://curecurrent.com/trials/comparison-of-biphasic-insulin-aspart-70-30-with-anti-diabetic-drugs-in-subjects-with-type-2-diabetes-6023 https://curecurrent.com/trials/a-study-to-determine-the-safety-and-efficacy-of-albiglutide-administered-in-combination-with-insulin-glargine-6024 https://curecurrent.com/trials/hepatic-dysfunction-vitamin-d-status-and-glycemic-control-in-diabetes-6025 https://curecurrent.com/trials/development-of-nic5-15-in-the-treatment-of-alzheimer-s-disease-6026 https://curecurrent.com/trials/biphasic-insulin-aspart-30-in-type-2-diabetes-failing-oad-therapy-6027 https://curecurrent.com/trials/the-synergy-to-control-emergency-department-hyperglycemia-program-for-type-2-diabetes-6028 https://curecurrent.com/trials/efficacy-and-safety-of-albiglutide-in-treatment-of-type-2-diabetes-6029 https://curecurrent.com/trials/a-study-to-determine-the-safety-and-efficacy-of-albiglutide-in-patients-with-type-2-diabetes-6030 https://curecurrent.com/trials/safety-and-efficacy-study-of-albiglutide-in-type-2-diabetes-6031 https://curecurrent.com/trials/pharmacokinetics-pharmacodynamics-of-albiglutide-6032 https://curecurrent.com/trials/a-study-to-determine-the-safety-and-efficacy-of-albiglutide-in-subjects-with-type-2-diabetes-6033 https://curecurrent.com/trials/safety-and-efficacy-of-albiglutide-in-type-2-diabetes-6034 https://curecurrent.com/trials/a-randomised-trial-evaluating-continuous-subcutaneous-infusion-of-formulations-of-nn1218-and-novolog-in-subjects-with-ty-6035 https://curecurrent.com/trials/reliability-of-dosing-with-novolog-mix-70-30-flexpen-compared-with-vial-and-syringe-6036 https://curecurrent.com/trials/januvia-sitagliptin-in-healing-chronic-diabetic-foot-ulcers-6037 https://curecurrent.com/trials/comparison-of-two-biphasic-insulin-aspart-30-formulations-current-and-new-formulation-in-healthy-volunteers-6038 https://curecurrent.com/trials/effects-of-biphasic-insulin-aspart-70-30-vs-exenatide-in-type-2-diabetes-patients-not-reaching-blood-glucose-targets-on-6039 https://curecurrent.com/trials/novolog-observation-trial-in-subjects-with-type-1-and-type-2-diabetes-6040 https://curecurrent.com/trials/efficacy-and-safety-of-lixisenatide-versus-insulin-glulisine-on-top-of-insulin-glargine-with-or-without-metformin-in-typ-6041 https://curecurrent.com/trials/prevention-trial-to-achieve-cardiovascular-targets-6042 https://curecurrent.com/trials/effect-of-metabolic-control-at-onset-of-diabetes-on-progression-of-type-1-diabetes-6043 https://curecurrent.com/trials/a-study-of-bms-512148-dapagliflozin-in-patients-with-type-2-diabetes-with-inadequately-controlled-hypertension-on-an-ace-6044 https://curecurrent.com/trials/insulin-aspart-vs-insulin-lispro-vs-regular-insulin-in-paediatric-population-6045 https://curecurrent.com/trials/safety-and-efficacy-of-novolog-vs-humalog-in-insulin-pumps-in-children-and-adolescents-6046 https://curecurrent.com/trials/safety-and-efficacy-of-insulin-aspart-vs-regular-human-insulin-in-gestational-diabetes-6047 https://curecurrent.com/trials/drug-interaction-with-metformin-6048 https://curecurrent.com/trials/evaluation-of-cardiovascular-outcomes-in-patients-with-type-2-diabetes-after-acute-coronary-syndrome-during-treatment-wi-6049 https://curecurrent.com/trials/bigfoot-biomedical-clinical-research-center-crc-trial-6050 https://curecurrent.com/trials/out-patient-study-in-patients-with-type-2-diabetes-mellitus-who-are-taking-no-diabetes-medication-or-metformin-only-6051 https://curecurrent.com/trials/glp-1-receptor-agonist-lixisenatide-morning-or-evening-in-patients-with-type-2-diabetes-for-glycemic-control-and-safety-6052 https://curecurrent.com/trials/dynamic-plantar-microvascular-skin-response-to-compressive-loads-in-at-risk-diabetic-and-healthy-control-a-pilot-study-6053 https://curecurrent.com/trials/glp-1-receptor-agonist-lixisenatide-in-patients-with-type-2-diabetes-for-glycemic-control-and-safety-evaluation-on-top-o-6054 https://curecurrent.com/trials/glp-1-receptor-agonist-lixisenatide-in-patients-with-type-2-diabetes-for-glycemic-control-and-safety-evaluation-on-top-o-6055 https://curecurrent.com/trials/a-pychoeducational-intervention-for-women-with-diabetes-6056 https://curecurrent.com/trials/glp-1-receptor-agonist-lixisenatide-in-patients-with-type-2-diabetes-for-glycemic-control-and-safety-evaluation-in-monot-6057 https://curecurrent.com/trials/metabolomic-profiling-of-novel-mediators-of-vascular-function-6058 https://curecurrent.com/trials/the-effects-of-apple-consumption-on-cardiovascular-health-in-prediabetics-and-type-2-diabetics-6059 https://curecurrent.com/trials/tart-cherry-metabolic-syndrome-and-cardiovascular-risk-6060 https://curecurrent.com/trials/comparison-of-nn5401-versus-insulin-glargine-both-combined-with-metformin-treatment-in-subjects-with-type-2-diabetes-6061 https://curecurrent.com/trials/pharmacodynamic-study-of-the-effect-of-incb013739-on-insulin-sensitivity-in-obese-type-2-diabetic-subjects-6062 https://curecurrent.com/trials/insulin-sensitivity-impaired-counterregulation-and-glucose-variability-6063 https://curecurrent.com/trials/glp-1-receptor-agonist-lixisenatide-versus-exenatide-in-patients-with-type-2-diabetes-for-glycemic-control-and-safety-ev-6064 https://curecurrent.com/trials/feasibility-of-a-partnered-approach-to-prevent-diabetes-6065 https://curecurrent.com/trials/glp-1-receptor-agonist-lixisenatide-in-patients-with-type-2-diabetes-for-glycemic-control-and-safety-evaluation-on-top-o-6066 https://curecurrent.com/trials/glp-1-receptor-agonist-lixisenatide-in-patients-with-type-2-diabetes-for-glycemic-control-and-safety-evaluation-on-top-o-6067 https://curecurrent.com/trials/effect-of-manual-medicine-or-cognitive-behavioral-therapy-with-chronic-uncontrolled-diabetes-6068 https://curecurrent.com/trials/a-type-2-diabetes-study-of-the-longer-term-glycemic-effect-of-avandamet-vs-metformin-6069 https://curecurrent.com/trials/action-to-control-cardiovascular-risk-in-diabetes-accord-6070 https://curecurrent.com/trials/overcoming-barriers-in-vision-care-utilization-of-african-americans-with-diabetes-6071 https://curecurrent.com/trials/sleep-intervention-for-youth-with-type-1-diabetes-6072 https://curecurrent.com/trials/impact-of-gastric-bypass-surgery-on-risk-of-cvd-in-type-2-diabetes-mellitus-6073 https://curecurrent.com/trials/integrated-population-program-for-diabetic-kidney-disease-6074 https://curecurrent.com/trials/efficacy-of-vildagliptin-100-mg-as-compared-to-placebo-as-add-on-to-metformin-in-patients-with-type-2-diabetes-6075 https://curecurrent.com/trials/safety-and-efficacy-of-vildagliptin-vs-thiazolidinedione-as-add-on-therapy-to-metformin-in-patients-with-type-2-diabetes-6076 https://curecurrent.com/trials/extension-to-a-study-on-the-efficacy-and-safety-of-vildagliptin-in-combination-with-insulin-in-patients-with-type-2-diab-6077 https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-vildagliptin-on-the-insulin-response-to-glucose-in-subjects-with-pre-diabetes-6078 https://curecurrent.com/trials/the-effect-of-linagliptin-on-mitochondrial-and-endothelial-function-6079 https://curecurrent.com/trials/safety-and-tolerability-of-escalating-intravenous-doses-of-pf-05231023-in-adult-subjects-with-type-2-diabetes-6080 https://curecurrent.com/trials/extension-to-a-study-on-the-efficacy-and-safety-of-vildagliptin-compared-to-metformin-in-drug-naive-patients-with-type-2-6081 https://curecurrent.com/trials/the-role-of-pulsatile-insulin-secretion-a-study-investigating-the-effects-of-partial-pacreatectomy-on-glucose-metabolism-6082 https://curecurrent.com/trials/a-trial-of-bms-512148-in-patients-with-type-2-diabetes-mellitus-6083 https://curecurrent.com/trials/characterization-of-the-kinetics-of-renal-glucose-reabsorption-in-response-to-dapagliflozin-in-healthy-subjects-and-in-s-6084 https://curecurrent.com/trials/study-of-subcutaneous-doses-of-hip2b-in-subjects-with-type-2-diabetes-mellitus-treated-with-metformin-6085 https://curecurrent.com/trials/behavioral-economic-incentives-to-improve-glycemic-control-among-adolescents-and-young-adults-6086 https://curecurrent.com/trials/comparing-visual-acuity-measurements-how-well-you-can-see-using-a-standard-etdrs-chart-a-handheld-etdrs-chart-6087 https://curecurrent.com/trials/pilot-study-of-hippocampal-function-in-type-1-diabetes-mellitus-t1dm-6088 https://curecurrent.com/trials/pilot-study-testing-feasibility-of-health-screening-at-farm-site-6089 https://curecurrent.com/trials/bioequivalence-study-of-two-albiglutide-drug-products-in-healthy-adult-subjects-6090 https://curecurrent.com/trials/efficacy-and-safety-study-of-arc-4558-for-management-of-pain-associated-with-painful-diabetic-neuropathy-6091 https://curecurrent.com/trials/the-association-between-peri-operative-hyperglycemia-and-major-morbidity-and-mortality-6092 https://curecurrent.com/trials/a-study-of-pf-05175157-in-healthy-volunteers-and-type-2-diabetic-patients-6093 https://curecurrent.com/trials/a-study-of-taspoglutide-versus-sitagliptin-for-the-treatment-of-patients-with-type-2-diabetes-mellitus-inadequately-cont-6094 https://curecurrent.com/trials/latinos-understanding-the-need-for-adherence-6095 https://curecurrent.com/trials/an-examination-of-the-blood-pressure-lowering-ability-and-safety-of-olmesartan-medoxomil-in-patients-with-type-ii-diabet-6096 https://curecurrent.com/trials/performance-of-an-investigational-blood-glucose-monitoring-system-in-a-clinical-setting-6097 https://curecurrent.com/trials/a-new-glucose-meter-with-alternative-site-testing-6098 https://curecurrent.com/trials/glycemic-control-brain-structure-and-cognition-in-youth-with-type-1-diabetes-t1dm-6099 https://curecurrent.com/trials/a-drug-drug-interaction-study-of-gk-activator-2-and-glyburide-in-patients-with-type-2-diabetes-6100 https://curecurrent.com/trials/a-study-on-the-potential-of-aleglitazar-to-reduce-cardiovascular-risk-in-patients-with-stable-cardiovascular-disease-and-6101 https://curecurrent.com/trials/a-drug-drug-interaction-study-of-gk-activator-2-and-simvastatin-in-patients-with-type-2-diabetes-6102 https://curecurrent.com/trials/a-study-of-gk-activator-2-in-patients-with-type-2-diabetes-mellitus-treated-with-a-stable-dose-of-metformin-6103 https://curecurrent.com/trials/a-study-with-aleglitazar-in-patients-with-a-recent-acute-coronary-syndrome-and-type-2-diabetes-mellitus-6104 https://curecurrent.com/trials/study-of-ro6807952-in-patients-with-diabetes-mellitus-type-2-6105 https://curecurrent.com/trials/a-multiple-ascending-dose-study-of-ro4998452-in-patients-with-type-2-diabetes-mellitus-6106 https://curecurrent.com/trials/a-safety-pharmacokinetics-and-pharmacodynamics-study-of-ro6811135-in-patients-with-type-2-diabetes-mellitus-6107 https://curecurrent.com/trials/a-study-of-a-glp-1-analogue-in-patients-with-type-2-diabetes-treated-with-metformin-6108 https://curecurrent.com/trials/a-study-of-dpp-iv-inhibitor-in-patients-with-type-2-diabetes-6109 https://curecurrent.com/trials/a-study-of-aleglitazar-in-combination-with-metformin-in-patients-with-type-2-diabetes-mellitus-who-are-inadequately-cont-6110 https://curecurrent.com/trials/a-study-of-dpp-iv-inhibitor-in-patients-with-type-2-diabetes-6111 https://curecurrent.com/trials/a-study-of-aleglitazar-in-patients-with-type-2-diabetes-6112 https://curecurrent.com/trials/a-pharmacodynamic-pharmacokinetic-study-of-aleglitazar-in-patients-with-type-2-diabetes-mellitus-on-treatment-with-lisin-6113 https://curecurrent.com/trials/a-study-of-ro5095932-in-patients-with-type-2-diabetes-mellitus-6114 https://curecurrent.com/trials/a-study-to-evaluate-the-long-term-safety-and-tolerability-of-gk-activator-2-in-patients-with-type-2-diabetes-6115 https://curecurrent.com/trials/a-study-with-ro5095932-in-patients-with-type-2-diabetes-on-stable-metformin-therapy-6116 https://curecurrent.com/trials/a-dose-titration-study-of-gk-activator-2-in-patients-with-type-2-diabetes-6117 https://curecurrent.com/trials/a-study-of-taspoglutide-versus-exenatide-for-the-treatment-of-patients-with-type-2-diabetes-mellitus-inadequately-contro-6118 https://curecurrent.com/trials/a-study-of-ro4998452-in-type-2-diabetes-patients-with-varying-degrees-of-renal-impairment-6119 https://curecurrent.com/trials/a-study-of-ro6807952-in-patients-with-diabetes-mellitus-type-2-6120 https://curecurrent.com/trials/a-study-of-gk-activator-2-in-patients-with-type-2-diabetes-mellitus-6121 https://curecurrent.com/trials/a-study-of-the-effect-of-renal-impairment-on-the-activity-of-gk-activator-2-in-patients-with-type-2-diabetes-6122 https://curecurrent.com/trials/a-study-of-taspoglutide-in-patients-with-inadequately-controlled-diabetes-mellitus-type-2-and-cardiovascular-disease-6123 https://curecurrent.com/trials/a-titration-study-of-a-glucagon-like-peptide-1-glp-1-analogue-in-patients-with-type-2-diabetes-treated-with-metformin-6124 https://curecurrent.com/trials/a-study-of-taspoglutide-versus-pioglitazone-in-patients-with-type-2-diabetes-6125 https://curecurrent.com/trials/adult-accuracy-study-of-the-enlite-3-glucose-sensor-6126 https://curecurrent.com/trials/connecting-smartphones-with-electronic-health-record-to-facilitate-behavioral-goal-monitoring-in-diabetes-care-6127 https://curecurrent.com/trials/the-diabetes-medication-adherence-promotion-intervention-trial-6128 https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-the-addition-of-canagliflozin-in-participants-with-type-2-diabetes-mellit-6129 https://curecurrent.com/trials/advancing-the-standard-of-care-for-pin-site-care-6130 https://curecurrent.com/trials/bioequivalence-of-two-novolog-formulations-in-subjects-with-type-1-diabetes-6131 https://curecurrent.com/trials/a-phase-iia-study-of-bms-512148-to-assess-safety-exposure-and-biological-effects-in-stable-type-2-diabetic-subjects-6132 https://curecurrent.com/trials/aliskiren-hctz-compared-to-amlodipine-in-patients-with-stage-2-systolic-hypertension-and-diabetes-mellitus-6133 https://curecurrent.com/trials/soy-supplementation-and-gestational-diabetes-6134 https://curecurrent.com/trials/an-exercise-intervention-to-prevent-gestational-diabetes-6135 https://curecurrent.com/trials/in-patient-study-with-gsk716155-in-patients-with-type-2-diabetes-mellitus-6136 https://curecurrent.com/trials/milk-fat-intake-and-metabolic-health-markers-6137 https://curecurrent.com/trials/bgat-blood-glucose-awareness-training-for-users-who-might-become-pregnant-6138 https://curecurrent.com/trials/t-and-b-cell-responses-in-autoimmune-diseases-6139 https://curecurrent.com/trials/characteristics-of-dendritic-cells-before-and-after-gastric-banding-6140 https://curecurrent.com/trials/pilot-stair-climbing-study-6141 https://curecurrent.com/trials/impact-of-a-diabetes-transitions-tool-kit-on-post-hospitalization-glycemic-control-6142 https://curecurrent.com/trials/a-pilot-feasibility-study-of-fibroblast-calcium-and-glucoregulation-in-health-and-disease-6143 https://curecurrent.com/trials/tracking-optical-coherence-tomography-6144 https://curecurrent.com/trials/development-of-a-comprehensive-ap-training-curriculum-for-adults-6145 https://curecurrent.com/trials/diet-and-metabolic-inflammation-6146 https://curecurrent.com/trials/addition-of-exenatide-to-insulin-glargine-in-type-2-diabetes-mellitus-6147 https://curecurrent.com/trials/effectiveness-of-autologel-therapy-in-diabetic-foot-ulcers-6148 https://curecurrent.com/trials/effects-of-sitagliptin-on-endothelial-function-in-type-2-diabetes-on-background-metformin-therapy-6149 https://curecurrent.com/trials/efficacy-of-autologel-therapy-to-usual-and-customary-care-in-wagner-gd-1-and-2-diabetic-foot-ulcers-6150 https://curecurrent.com/trials/rosiglitazone-induced-weight-gain-6151 https://curecurrent.com/trials/the-effect-of-real-time-continuous-glucose-monitoring-in-subjects-with-pre-diabetes-6152 https://curecurrent.com/trials/randomized-trial-to-assess-efficacy-and-safety-of-continuous-glucose-monitoring-in-children-4-10-years-with-t1dm-6153 https://curecurrent.com/trials/continuous-glucose-sensor-profiles-in-non-diabetic-subjects-6154 https://curecurrent.com/trials/novofine-autocover-safety-needle-versus-bd-safety-glide-6155 https://curecurrent.com/trials/minnesota-medicaid-incentives-to-prevent-chronic-disease-6156 https://curecurrent.com/trials/a-study-of-the-treatment-of-type-2-diabetes-with-an-insulin-infusion-pump-6157 https://curecurrent.com/trials/health-economic-assessment-of-lower-extremity-diabetic-healed-ulcers-with-primatrix-6158 https://curecurrent.com/trials/renal-mechanism-of-action-splay-vs-tmg-6159 https://curecurrent.com/trials/pharmacokinetic-drug-interaction-study-of-dapagliflozin-and-valsartan-or-simvastatin-in-healthy-subjects-6160 https://curecurrent.com/trials/pharmacodynamics-pharmacokinetics-safety-and-tolerability-of-ultra-low-doses-of-dapagliflozin-in-healthy-subjects-6161 https://curecurrent.com/trials/effect-of-rifampin-on-the-pharmacokinetics-of-dapagliflozin-in-healthy-subjects-6162 https://curecurrent.com/trials/study-of-the-effect-of-dapagliflozin-on-the-pharmacokinetics-of-warfarin-or-digoxin-in-healthy-subjects-6163 https://curecurrent.com/trials/renal-impairment-in-type-2-diabetic-subjects-6164 https://curecurrent.com/trials/pharmacodynamic-effect-of-prasugrel-vs-ticagrelor-in-diabetes-6165 https://curecurrent.com/trials/bioavailability-study-of-fixed-dose-combination-fdc-formulations-of-dapagliflozin-and-metformin-xr-versus-individual-com-6166 https://curecurrent.com/trials/a-single-site-randomized-double-blind-placebo-controlled-trial-of-nic5-15-in-subjects-with-alzheimer-s-disease-6167 https://curecurrent.com/trials/a-phase-2-multi-center-study-to-compare-the-efficacy-and-safety-of-a-chemokine-ccr2-5-receptor-antagonist-with-ranibizum-6168 https://curecurrent.com/trials/study-of-the-absolute-oral-bioavailability-of-dapagliflozin-in-healthy-subjects-6169 https://curecurrent.com/trials/pharmacokinetic-drug-interaction-study-of-dapagliflozin-and-glimepiride-or-sitagliptin-in-healthy-subjects-6170 https://curecurrent.com/trials/study-to-evaluate-the-potential-pharmacokinetic-interaction-and-pharmacodynamic-effects-on-renal-parameters-of-bumetanid-6171 https://curecurrent.com/trials/the-public-private-partnership-addressing-literacy-numeracy-to-improve-diabetes-care-6172 https://curecurrent.com/trials/comparison-of-lixisenatide-injected-prior-to-the-main-meal-of-the-day-versus-prior-to-breakfast-in-type-2-diabetic-patie-6173 https://curecurrent.com/trials/at-home-study-of-a-zone-model-predictive-control-mpc-controller-and-a-health-monitoring-system-hms-with-the-diabetes-ass-6174 https://curecurrent.com/trials/glycemic-response-to-three-oral-nutrition-supplements-in-persons-with-type-2-diabetes-mellitus-6175 https://curecurrent.com/trials/glycemic-response-to-two-enteral-formulas-in-persons-with-type-2-diabetes-mellitus-6176 https://curecurrent.com/trials/24-week-treatment-with-lixisenatide-in-type-2-diabetes-insufficiently-controlled-with-metformin-and-insulin-glargine-6177 https://curecurrent.com/trials/24-week-study-comparing-lixisenatide-to-sitagliptin-as-add-on-to-metformin-in-obese-type-2-diabetic-patients-younger-tha-6178 https://curecurrent.com/trials/evaluation-of-biomarker-expression-in-diabetic-and-healthy-subjects-over-a-one-year-period-6179 https://curecurrent.com/trials/fasiglifam-25-mg-bid-vs-50-mg-qd-6180 https://curecurrent.com/trials/the-effect-of-pregabalin-on-pain-related-to-walking-in-patients-with-diabetic-peripheral-neuropathy-6181 https://curecurrent.com/trials/protein-kinase-c-pkc-inhibitor-diabetic-retinopathy-phase-3-study-6182 https://curecurrent.com/trials/multi-layer-insoles-for-a-patient-specific-approach-to-shear-and-pressure-reduction-in-diabetes-related-foot-ulcer-6183 https://curecurrent.com/trials/effect-of-ruboxistaurin-on-clinically-significant-macular-edema-6184 https://curecurrent.com/trials/treatment-for-completers-of-the-study-b7a-mc-mbcm-6185 https://curecurrent.com/trials/reduction-in-the-occurrence-of-center-involved-diabetic-macular-edema-6186 https://curecurrent.com/trials/diabetes-prevention-and-control-in-the-workplace-a-pilot-study-6187 https://curecurrent.com/trials/feet-first-promoting-physical-activity-among-people-with-diabetes-mellitus-and-insensate-feet-6188 https://curecurrent.com/trials/evaluation-of-the-dpp-4-inhibitor-sitagliptin-in-the-treatment-of-non-alcoholic-fatty-liver-disease-using-mri-6189 https://curecurrent.com/trials/effects-of-colesevelam-hcl-rosiglitazone-sitagliptin-on-control-of-blood-glucose-and-lipids-in-type-2-diabetes-patients-6190 https://curecurrent.com/trials/safety-tolerability-and-preliminary-efficacy-of-azd5213-in-combination-with-pregabalin-in-subjects-with-pdn-and-good-pai-6191 https://curecurrent.com/trials/effects-of-febuxostat-on-adipokines-and-kidney-disease-in-diabetic-chronic-kidney-disease-6192 https://curecurrent.com/trials/extended-work-schedules-sleep-loss-and-health-6193 https://curecurrent.com/trials/integrating-targeted-medlineplus-health-prescriptions-into-clinic-practice-workflow-6194 https://curecurrent.com/trials/effect-of-a-basal-pre-meal-insulin-strategy-detemir-aspart-on-insulin-secretion-and-action-in-type-2-diabetes-6195 https://curecurrent.com/trials/adding-exenatide-to-insulin-therapy-for-patients-with-type-2-diabetes-and-non-alcoholic-fatty-liver-disease-6196 https://curecurrent.com/trials/study-of-topical-ocular-pan-90806-in-pdr-6197 https://curecurrent.com/trials/study-of-two-dosing-regimens-of-pf-04937319-compared-to-an-approved-agent-sitagliptin-in-patients-with-type-2-diabetes-6198 https://curecurrent.com/trials/effect-of-reminders-on-adherence-6199 https://curecurrent.com/trials/adult-subjects-with-uncontrolled-type-2-diabetes-6200 https://curecurrent.com/trials/phase-2-study-to-evaluate-safety-efficacy-of-rm-131-administered-to-patients-with-diabetic-gastroparesis-6201 https://curecurrent.com/trials/a-prospective-clinical-trial-of-the-tantalus-system-in-treatment-of-obese-to-morbidly-obese-patients-6202 https://curecurrent.com/trials/study-to-assess-pharmacodynamics-of-rm-131-in-patients-with-diabetic-gastroparesis-6203 https://curecurrent.com/trials/a-primary-care-ehr-based-strategy-to-promote-safe-and-appropriate-drug-use-6204 https://curecurrent.com/trials/the-blossom-project-blossomup-methods-to-decrease-sedentary-time-in-pregnancy-6205 https://curecurrent.com/trials/assessing-the-pk-and-effect-on-glucose-and-gi-hormone-concentrations-of-metformin-delayed-release-in-subjects-with-t2dm-6206 https://curecurrent.com/trials/pharmacokinetic-single-dose-trial-of-empagliflozin-in-children-and-adolescents-with-type-2-diabetes-mellitus-6207 https://curecurrent.com/trials/rosiglitazone-in-subjects-with-type-2-diabetes-mellitus-who-are-inadequately-controlled-on-insulin-6208 https://curecurrent.com/trials/rosiglitazone-on-microalbuminuria-in-type-2-diabetics-6209 https://curecurrent.com/trials/finding-a-safe-and-effective-dose-of-linagliptin-in-pediatric-patients-with-type-2-diabetes-6210 https://curecurrent.com/trials/diabetic-treatment-adherence-6211 https://curecurrent.com/trials/validation-of-an-rlip76-assay-in-humans-6212 https://curecurrent.com/trials/inpatient-evaluation-of-an-automated-closed-loop-control-to-range-system-6213 https://curecurrent.com/trials/pharmacokinetic-comparison-of-intradermal-versus-sub-cutaneous-insulin-and-glucagon-delivery-in-type-1-diabetes-6214 https://curecurrent.com/trials/hormone-responses-during-hypoglycemia-and-the-accuracy-of-continuous-glucose-monitors-6215 https://curecurrent.com/trials/pilot-study-of-the-navigator-continuous-glucose-monitor-6216 https://curecurrent.com/trials/pilot-study-of-the-glucowatch-g2-biographer-for-the-management-of-type-1-diabetes-in-children-6217 https://curecurrent.com/trials/study-to-determine-the-relationship-between-exercise-and-hypoglycemia-in-children-with-type-1-diabetes-6218 https://curecurrent.com/trials/continuous-glucose-monitors-for-children-with-diabetes-mellitus-6219 https://curecurrent.com/trials/the-effect-of-insulin-during-exercise-on-the-development-of-low-blood-sugar-in-individuals-with-type-i-diabetes-6220 https://curecurrent.com/trials/effect-of-the-fat-content-of-the-bedtime-snack-on-overnight-hypoglycemia-6221 https://curecurrent.com/trials/study-of-stress-hyperglycemia-as-an-indicator-of-diabetes-mellitus-6222 https://curecurrent.com/trials/a-pilot-study-to-evaluate-the-safety-of-terbutaline-in-children-with-type-1-diabetes-6223 https://curecurrent.com/trials/randomized-clinical-trial-to-assess-the-effectiveness-of-the-glucowatch-biographer-6224 https://curecurrent.com/trials/assessing-continuous-glucose-monitors-in-healthy-children-6225 https://curecurrent.com/trials/efficacy-and-safety-of-empagliflozin-bi-10773-with-metformin-in-patients-with-type-2-diabetes-6226 https://curecurrent.com/trials/tandem-predictive-low-glucose-suspend-inpatient-feasibility-study-6227 https://curecurrent.com/trials/tak-648-multiple-rising-dose-study-in-healthy-japanese-participants-and-non-japanese-participants-with-type-2-diabetes-m-6228 https://curecurrent.com/trials/a-novel-positron-emission-tomography-pet-approach-to-measuring-myocardial-metabolism-6229 https://curecurrent.com/trials/outpatient-pump-shutoff-pilot-feasibility-and-efficacy-study-6230 https://curecurrent.com/trials/outpatient-reduction-of-nocturnal-hypoglycemia-by-using-predictive-algorithms-and-pump-suspension-in-children-6231 https://curecurrent.com/trials/an-outpatient-pump-shutoff-pilot-feasibility-and-safety-study-6232 https://curecurrent.com/trials/pharmacokinetic-study-of-cycloset-0-8-mg-tablets-in-children-and-adolescent-type-2-diabetes-mellitus-subjects-6233 https://curecurrent.com/trials/laser-ranibizumab-triamcinolone-for-proliferative-diabetic-retinopathy-6234 https://curecurrent.com/trials/a-phase-2-evaluation-of-anti-vegf-therapy-for-diabetic-macular-edema-bevacizumab-avastin-6235 https://curecurrent.com/trials/effect-of-diabetes-education-during-retinal-ophthalmology-visits-on-diabetes-control-6236 https://curecurrent.com/trials/the-course-of-response-to-focal-photocoagulation-for-dme-6237 https://curecurrent.com/trials/way-to-health-healthy-measures-6238 https://curecurrent.com/trials/study-of-ro-205-2349-in-patients-with-type-2-diabetes-mellitus-6239 https://curecurrent.com/trials/a-study-to-evaluate-safety-pharmacokinetics-and-pharmacodynamics-of-escalating-doses-of-sar438544-in-comparison-to-place-6240 https://curecurrent.com/trials/surgery-or-lifestyle-intervention-for-type-2-diabetes-solid-6241 https://curecurrent.com/trials/insulin-resistance-in-the-control-of-intestinal-lipid-metabolism-6242 https://curecurrent.com/trials/lisofylline-as-continuous-subcutaneous-and-intravenous-administration-in-subjects-with-type-1-diabetes-mellitus-6243 https://curecurrent.com/trials/relationship-between-changes-in-gut-hormones-after-gastric-bypass-and-gastric-banding-and-improvements-in-diabetes-6244 https://curecurrent.com/trials/immunobiology-of-diabetes-and-tuberculosis-6245 https://curecurrent.com/trials/study-of-amniotic-membrane-graft-in-the-management-of-diabetic-foot-ulcers-6246 https://curecurrent.com/trials/leptin-to-treat-lipodystrophy-6247 https://curecurrent.com/trials/telehealth-intervention-for-youth-with-t1dm-6248 https://curecurrent.com/trials/evaluating-cvd-medication-adherence-program-in-low-ses-6249 https://curecurrent.com/trials/a-study-of-aleglitazar-in-patients-with-type-2-diabetes-mellitus-who-have-not-previously-received-anti-hyperglycemic-the-6250 https://curecurrent.com/trials/actos-now-for-prevention-of-diabetes-act-now-6251 https://curecurrent.com/trials/hormones-and-sexual-function-predict-outcomes-in-revascularized-men-with-diabetes-6252 https://curecurrent.com/trials/effect-pulsatile-iv-insulin-therapy-on-the-quality-of-life-in-patients-with-types-1-and-2-diabetes-6253 https://curecurrent.com/trials/effects-of-pulsatile-intravenous-insulin-delivery-on-diabetic-neuropathy-in-patients-pts-with-type-1-and-type-2-diabetes-6254 https://curecurrent.com/trials/a-prospective-collection-of-peripheral-blood-and-urine-specimens-to-study-c-peptide-and-insulin-in-healthy-individuals-6255 https://curecurrent.com/trials/effects-of-pulsatile-iv-insulin-delivery-on-diabetic-retinopathy-in-patients-with-types-1-and-2-diabetes-mellitus-6256 https://curecurrent.com/trials/effects-of-pulsatile-insulin-delivery-on-diabetic-neuropathy-in-patients-with-types-1-and-2-diabetes-mellitus-6257 https://curecurrent.com/trials/effects-of-pulsatile-intravenous-insulin-therapy-on-metabolic-integrity-in-patients-with-diabetes-mellitus-6258 https://curecurrent.com/trials/effects-of-pulsatile-intravenous-iv-insulin-on-wound-healing-in-diabetics-6259 https://curecurrent.com/trials/effects-of-pulsatile-intravenous-insulin-therapy-on-cardiac-disease-in-patients-with-diabetes-6260 https://curecurrent.com/trials/effects-of-pulsatile-intravenous-insulin-delivery-on-hypoglycemic-unawareness-6261 https://curecurrent.com/trials/clinical-effects-of-pulsatile-insulin-delivery-on-cognitive-function-phase-1-6262 https://curecurrent.com/trials/effects-of-krill-oil-on-endothelial-function-in-patients-with-type-2-diabetes-mellitus-6263 https://curecurrent.com/trials/medtable-an-electronic-medical-record-emr-strategy-to-promote-patient-medication-understanding-and-use-6264 https://curecurrent.com/trials/glycaemic-control-of-monthly-laps-exendin-versus-placebo-in-subjects-of-type-2-diabetes-6265 https://curecurrent.com/trials/glycaemic-control-of-weekly-laps-exendin-versus-placebo-in-subjects-of-type-2-diabetes-6266 https://curecurrent.com/trials/effect-of-laps-exendin-on-body-weight-in-obese-population-6267 https://curecurrent.com/trials/the-effect-of-renin-inhibition-on-nerve-function-in-diabetes-6268 https://curecurrent.com/trials/effect-of-pulsatile-iv-insulin-on-circulating-risk-markers-of-vascular-and-metabolic-complications-in-pts-with-diabetes-6269 https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-pharmacodynamics-study-of-laps-exendin-in-subjects-of-type-2-diabetes-mellitus-6270 https://curecurrent.com/trials/diabetes-go-mobile-pilot-study-6271 https://curecurrent.com/trials/the-inova-type-2-diabetes-mellitus-study-6272 https://curecurrent.com/trials/a-study-of-dipeptidyl-peptidase-iv-dpp-iv-ro4876904-in-patients-with-type-2-diabetes-6273 https://curecurrent.com/trials/a-study-of-taspoglutide-versus-placebo-for-the-treatment-of-patients-with-type-2-diabetes-mellitus-inadequately-controll-6274 https://curecurrent.com/trials/a-comparative-study-of-aleglitazar-and-actos-in-patients-with-type-2-diabetes-mellitus-and-new-york-heart-association-ny-6275 https://curecurrent.com/trials/a-comparison-of-the-effects-of-aleglitazar-and-actos-on-renal-function-on-patients-with-type-2-diabetes-6276 https://curecurrent.com/trials/identifying-genes-that-may-increase-the-risk-for-heart-disease-in-african-americans-6277 https://curecurrent.com/trials/an-intervention-trial-for-cardiac-neuropathy-in-type-1-diabetes-6278 https://curecurrent.com/trials/a-study-of-the-safety-tolerability-and-effect-on-glycemic-control-of-taspoglutide-versus-insulin-glargine-in-insulin-nai-6279 https://curecurrent.com/trials/a-study-of-ro5093151-and-ro5027838-in-patients-with-type-2-diabetes-mellitus-on-a-stable-dose-of-metformin-6280 https://curecurrent.com/trials/a-study-of-taspoglutide-versus-placebo-for-the-treatment-of-patients-with-type-2-diabetes-mellitus-inadequately-controll-6281 https://curecurrent.com/trials/l-arginine-vascular-response-and-mechanisms-6282 https://curecurrent.com/trials/a-study-of-taspoglutide-versus-placebo-for-the-treatment-of-obese-patients-with-type-2-diabetes-mellitus-inadequately-co-6283 https://curecurrent.com/trials/islet-transplantation-using-abatacept-6284 https://curecurrent.com/trials/effect-of-ly333531-on-vascular-and-neural-functions-6285 https://curecurrent.com/trials/isoprostane-fmd-study-the-effect-of-protein-kinase-c-pkc-specific-inhibitor-ly333531-on-oxidant-stress-in-patients-with-6286 https://curecurrent.com/trials/a-pilot-study-using-weightloss-and-exercise-to-prevent-recurring-gestational-diabetes-in-obese-women-6287 https://curecurrent.com/trials/treatment-for-symptomatic-peripheral-neuropathy-in-patients-with-diabetes-6288 https://curecurrent.com/trials/the-effect-of-ruboxistaurin-on-small-fiber-function-6289 https://curecurrent.com/trials/training-pain-connoisseurs-for-efficient-analgesic-proof-of-concept-studies-6290 https://curecurrent.com/trials/feasibility-study-of-pid-versus-mpc-and-hms-6291 https://curecurrent.com/trials/mpc-versus-pid-for-closed-loop-insulin-delivery-6292 https://curecurrent.com/trials/effects-of-ppar-ligands-on-ectopic-fat-accumulation-and-inflammation-6293 https://curecurrent.com/trials/ability-to-cope-with-type-1-diabetes-6294 https://curecurrent.com/trials/a-survey-to-elicit-the-relationship-between-literacy-and-glycemic-control-in-pediatric-diabetes-6295 https://curecurrent.com/trials/bmi-and-its-relationship-to-hypoglycemic-seizures-in-children-with-insulin-requiring-diabetes-6296 https://curecurrent.com/trials/disaster-preparedness-among-families-caring-for-children-with-diabetes-6297 https://curecurrent.com/trials/full-day-and-night-closed-loop-with-dias-platform-6298 https://curecurrent.com/trials/a-study-of-effects-of-canagliflozin-as-add-on-therapy-to-insulin-in-the-treatment-of-participants-with-type-1-diabetes-m-6299 https://curecurrent.com/trials/islet-transplantation-in-type-1-diabetics-using-the-edmonton-protocol-of-steroid-free-immunosuppression-6300 https://curecurrent.com/trials/ability-to-cope-with-type-1-diabetes-6301 https://curecurrent.com/trials/lantus-in-the-treatment-of-type-1-diabetes-children-6302 https://curecurrent.com/trials/continuous-subcutaneous-infusion-of-pramlintide-and-insulin-6303 https://curecurrent.com/trials/the-role-of-amylin-and-glucagon-in-t1dm-6304 https://curecurrent.com/trials/the-effect-of-prolonged-pramlintide-infusion-in-pediatric-diabetes-6305 https://curecurrent.com/trials/safety-and-efficacy-of-dextromethorphan-and-quinidine-in-the-treatment-of-the-pain-of-diabetic-neuropathy-6306 https://curecurrent.com/trials/gestational-diabetes-and-sleep-disordered-breathing-6307 https://curecurrent.com/trials/lunch-time-insulin-injection-by-school-nurse-for-poorly-controlled-diabetes-6308 https://curecurrent.com/trials/evaluation-of-a-nutritional-supplement-for-people-with-type-2-diabetes-6309 https://curecurrent.com/trials/evaluating-the-impact-of-year-long-augmented-diabetes-self-management-support-6310 https://curecurrent.com/trials/improving-neurologic-outcomes-in-people-with-diabetes-who-are-undergoing-heart-surgery-6311 https://curecurrent.com/trials/study-of-dapagliflozin-in-combination-with-metformin-xr-to-initiate-the-treatment-of-type-2-diabetes-6312 https://curecurrent.com/trials/loop-duodenal-switch-surgery-in-morbidly-obese-patients-6313 https://curecurrent.com/trials/study-of-the-acute-metabolic-effect-of-exenatide-in-type-1-diabetes-6314 https://curecurrent.com/trials/effect-of-amount-and-type-of-dietary-carbohydrates-on-risk-for-cardiovascular-heart-disease-and-diabetes-6315 https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-isis-gcgrrx-in-type-2-diabetes-6316 https://curecurrent.com/trials/evaluation-of-group-lifestyle-balance-dvd-in-primary-care-practice-6317 https://curecurrent.com/trials/n-acetylcysteine-and-milk-thistle-for-treatment-of-diabetic-nephropathy-6318 https://curecurrent.com/trials/implementation-of-a-population-health-chronic-disease-management-program-6319 https://curecurrent.com/trials/evaluation-of-group-lifestyle-balance-maintenance-strategies-6320 https://curecurrent.com/trials/a-performance-evaluation-of-the-enlite-3-sensor-6321 https://curecurrent.com/trials/a-phase-i-study-to-assess-the-pharmacodynamics-of-oral-ar-c165395xx-in-subjects-with-type-2-diabetes-mellitus-t2dm-6322 https://curecurrent.com/trials/mild-compression-sock-for-control-of-lower-extremity-edema-in-individuals-with-diabetes-6323 https://curecurrent.com/trials/efficacy-of-syr-472-in-subjects-with-type-2-diabetes-mellitus-6324 https://curecurrent.com/trials/safety-and-efficacy-of-dapagliflozin-in-triple-therapy-to-treat-subjects-with-type-2-diabetes-6325 https://curecurrent.com/trials/efficacy-and-safety-of-syr-472-in-subjects-with-type-2-diabetes-mellitus-6326 https://curecurrent.com/trials/does-pioglitazone-increase-the-production-of-15-epi-lipoxin-a4-6327 https://curecurrent.com/trials/efficacy-and-safety-of-tak-583-in-subjects-with-diabetic-peripheral-neuropathy-6328 https://curecurrent.com/trials/study-of-the-use-of-niaspan-for-treatment-of-dyslipidemia-in-diabetic-nephropathy-6329 https://curecurrent.com/trials/efficacy-and-safety-of-tak-379-in-adult-subjects-with-type-2-diabetes-mellitus-6330 https://curecurrent.com/trials/the-metabolic-effects-of-almond-consumption-in-adults-with-pre-diabetes-6331 https://curecurrent.com/trials/lay-user-trial-of-the-iglucose-blood-glucose-monitoring-system-6332 https://curecurrent.com/trials/southeastern-diabetes-initiative-clinical-intervention-6333 https://curecurrent.com/trials/effect-of-the-anti-oxidant-n-acetylcysteine-on-beta-cell-function-in-type-2-diabetes-6334 https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-study-of-pf-06291874-as-oral-monotherapy-to-treat-adults-with-6335 https://curecurrent.com/trials/study-of-the-relationship-between-blood-vessels-and-insulin-response-in-adolescents-6336 https://curecurrent.com/trials/insulin-treatment-variation-in-southwestern-diabetics-6337 https://curecurrent.com/trials/artificial-pancreas-control-system-in-an-inpatient-setting-6338 https://curecurrent.com/trials/a-study-of-effectiveness-and-safety-of-jnj-42160443-in-patients-with-diabetic-painful-neuropathy-6339 https://curecurrent.com/trials/comparison-of-fasiglifam-tak-875-to-placebo-and-sitagliptin-in-combination-with-metformin-in-participants-with-type-2-di-6340 https://curecurrent.com/trials/pet-ownership-and-glucose-control-in-type-1-diabetes-6341 https://curecurrent.com/trials/improving-metabolic-assessments-in-type-1-diabetes-mellitus-clinical-trials-6342 https://curecurrent.com/trials/a-study-to-evaluate-itca-650-compared-to-sitagliptin-as-add-on-therapy-for-the-treatment-of-type-2-diabetes-6343 https://curecurrent.com/trials/comparison-of-tak-875-to-placebo-as-an-add-on-to-glimepiride-in-patients-with-type-2-diabetes-6344 https://curecurrent.com/trials/tak-875-fasiglifam-in-combination-with-sitagliptin-in-adults-with-type-2-diabetes-6345 https://curecurrent.com/trials/efficacy-and-safety-of-tak-875-compared-to-glimepiride-when-used-with-metformin-in-participants-with-type-2-diabetes-6346 https://curecurrent.com/trials/resistance-to-antibiotics-in-patients-receiving-eye-injections-6347 https://curecurrent.com/trials/squalamine-lactate-eye-drops-in-combination-with-ranibizumab-in-patients-with-diabetic-macular-edema-dme-6348 https://curecurrent.com/trials/study-of-intravitreal-aflibercept-injection-iai-eylea-bay86-5321-in-patients-with-diabetic-macular-edema-6349 https://curecurrent.com/trials/reach-detroit-partnership-family-intervention-6350 https://curecurrent.com/trials/open-label-extension-study-to-evaluate-long-term-safety-and-treatment-effect-of-diapep277-6351 https://curecurrent.com/trials/efficacy-and-safety-of-m100907-on-sleep-maintenance-insomnia-with-a-sub-study-in-stable-type-ii-diabetes-mellitus-6352 https://curecurrent.com/trials/efficacy-and-safety-study-of-diapep277-in-newly-diagnosed-type-1-diabetes-adults-6353 https://curecurrent.com/trials/efficacy-an-safety-of-volinanserin-on-sleep-maintenance-insomnia-with-a-sub-study-on-stable-type-ii-diabetes-mellitus-6354 https://curecurrent.com/trials/omt-of-somatic-dysfunction-and-chronic-low-back-pain-in-patients-with-type-2-diabetes-mellitus-6355 https://curecurrent.com/trials/exenatide-pregnancy-registry-type-2-diabetes-in-pregnancy-6356 https://curecurrent.com/trials/use-of-decision-aids-in-clinical-encounters-6357 https://curecurrent.com/trials/effects-of-a-high-protein-diet-on-clinical-outcomes-in-heart-failure-6358 https://curecurrent.com/trials/comparison-of-the-ability-of-glulisine-with-lispro-to-control-type-1-diabetes-mellitus-in-children-and-adolescents-6359 https://curecurrent.com/trials/defective-atypical-protein-kinase-c-pkc-activation-in-diabetes-and-metabolic-syndrome-6360 https://curecurrent.com/trials/assessment-of-the-safety-of-sar342434-and-humalog-when-administered-as-continuous-subcutaneous-insulin-infusion-6361 https://curecurrent.com/trials/exploring-the-effectiveness-of-sensor-based-balance-training-on-patient-outcome-measures-6362 https://curecurrent.com/trials/correlation-of-continuous-glucose-monitoring-and-glucose-tolerance-testing-with-pregnancy-outcomes-6363 https://curecurrent.com/trials/an-efficacy-and-safety-study-of-rimonabant-for-treatment-of-nonalcoholic-steatohepatitis-nash-in-patients-with-type-2-di-6364 https://curecurrent.com/trials/a-comparison-study-of-the-bioavailability-of-a-capsule-formulation-of-lgd-6972-to-an-oral-solution-formulation-6365 https://curecurrent.com/trials/rimonabant-in-prediabetic-subjects-to-delay-onset-of-type-2-diabetes-6366 https://curecurrent.com/trials/glycemic-impact-of-myo-inositol-in-pregnancy-6367 https://curecurrent.com/trials/an-efficacy-and-safety-study-of-rimonabant-for-treatment-of-nonalcoholic-steatohepatitis-nash-in-patients-without-diabet-6368 https://curecurrent.com/trials/effect-of-rimonabant-and-metformin-combination-on-glycemic-control-in-patients-with-type-2-diabetes-6369 https://curecurrent.com/trials/participatory-design-of-patient-centered-depression-and-diabetes-care-6370 https://curecurrent.com/trials/the-use-of-bioscaffolds-in-conjunction-with-negative-pressure-therapy-a-prospective-randomized-double-blinded-trial-6371 https://curecurrent.com/trials/study-of-rimonabant-metformin-combinations-to-investigate-diabetes-blood-sugar-control-in-patients-with-type-2-diabetes-6372 https://curecurrent.com/trials/effects-of-tnf-alpha-antagonism-etanercept-in-patients-with-the-metabolic-syndrome-and-psoriasis-6373 https://curecurrent.com/trials/effect-of-exenatide-on-liver-and-heart-fat-and-inflammation-6374 https://curecurrent.com/trials/bi-10773-empagliflozin-cardiovascular-outcome-event-trial-in-type-2-diabetes-mellitus-patients-empa-reg-outcome-6375 https://curecurrent.com/trials/a-glycemic-control-evaluation-of-glimepiride-versus-rimonabant-on-top-of-metformin-in-type-2-diabetes-6376 https://curecurrent.com/trials/do-patient-centric-mhealth-programs-improve-patient-engagement-and-health-outcomes-6377 https://curecurrent.com/trials/t-cell-validation-study-using-blood-samples-from-subjects-with-recent-onset-type-1-diabetes-mellitus-6378 https://curecurrent.com/trials/soybean-oil-trial-of-cardiovascular-risk-6379 https://curecurrent.com/trials/impact-of-sleep-and-meal-timing-on-food-intake-regulation-6380 https://curecurrent.com/trials/study-of-regn1193-in-patients-with-type-2-diabetes-mellitus-6381 https://curecurrent.com/trials/v2-receptor-effects-on-fluid-regulation-and-performance-6382 https://curecurrent.com/trials/pgc-1-muscle-mitochondrial-dysfunction-in-diabetes-6383 https://curecurrent.com/trials/mobile-application-to-enhance-diabetic-care-6384 https://curecurrent.com/trials/glycemic-profile-in-women-with-gestational-diabetes-treated-with-glyburide-6385 https://curecurrent.com/trials/shared-decision-making-with-pharmaceutical-care-6386 https://curecurrent.com/trials/a-comparison-study-of-prototype-continuous-glucose-sensors-in-the-intradermal-and-subcutaneous-spaces-6387 https://curecurrent.com/trials/beneficial-effect-of-salicylates-insulin-action-secretion-or-clearance-6388 https://curecurrent.com/trials/effect-of-single-dose-pf-05175157-on-metabolic-and-cardiopulmonary-parameters-6389 https://curecurrent.com/trials/a-6-week-study-to-determine-the-safety-and-effect-of-an-investigational-drug-given-with-canagliflozin-in-adults-with-typ-6390 https://curecurrent.com/trials/a-6-week-study-to-determine-the-safety-and-effect-of-an-investigational-drug-on-adults-with-type-2-diabetes-mellitus-tak-6391 https://curecurrent.com/trials/early-phase-pre-clinical-and-initial-clinical-research-on-epicatechin-part-2-6392 https://curecurrent.com/trials/the-effects-of-micronutrients-in-combination-with-usual-care-in-type-2-diabetes-6393 https://curecurrent.com/trials/move-out-a-partnership-with-veterans-groups-to-enhance-weight-management-in-the-veterans-health-administration-vha-6394 https://curecurrent.com/trials/relationship-between-gastric-emptying-and-glycemic-variability-in-type-1-diabetes-mellitus-6395 https://curecurrent.com/trials/strategies-to-improve-islet-survival-6396 https://curecurrent.com/trials/diabetes-prevention-strategies-in-women-with-gestational-diabetes-mellitus-gdm-6397 https://curecurrent.com/trials/ranibizumab-0-5mg-and-2-0mg-to-treat-diabetic-macular-edema-in-patients-with-poor-response-to-bevacizumab-6398 https://curecurrent.com/trials/safety-and-efficacy-of-saxagliptin-in-triple-therapy-to-treat-subjects-with-type-2-diabetes-6399 https://curecurrent.com/trials/outpatient-control-to-range-system-and-monitoring-testing-6400 https://curecurrent.com/trials/peer-supported-diabetes-self-management-support-6401 https://curecurrent.com/trials/activator-and-type-ii-diabetics-6402 https://curecurrent.com/trials/doctors-and-web-based-self-management-support-pilot-study-6403 https://curecurrent.com/trials/spanish-diabetes-self-management-program-6404 https://curecurrent.com/trials/expressive-writing-for-reducing-stress-and-diabetic-symptoms-in-diabetes-patients-6405 https://curecurrent.com/trials/effect-of-the-insupatch-on-automated-closed-loop-glucose-control-in-type-1-diabetes-6406 https://curecurrent.com/trials/neuropsychological-and-neuroanatomical-studies-of-young-children-with-and-without-type-1-diabetes-mellitus-6407 https://curecurrent.com/trials/continuous-glucose-monitor-use-in-school-6408 https://curecurrent.com/trials/the-effects-of-high-and-low-blood-glucose-values-on-the-brain-in-children-with-type-1-diabetes-mellitus-6409 https://curecurrent.com/trials/g5-mobile-continuous-glucose-monitoring-system-automated-vs-manual-sensor-applicator-6410 https://curecurrent.com/trials/boosting-emotions-happiness-in-outpatients-living-with-diabetes-6411